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GENERAL INTRODUCTION 
Cadmium is one of the most toxic elements in the 
environment. Its relatively rapid uptake and accumulation 
by the food chain contributes to the risks posed by its 
hazardous nature. Humans are exposed to cadmium primarily 
through food and cigarette smoking. It accumulates in all 
of the body organs. When the concentration in the human 
body reaches a certain threshold level, kidney damage and 
skeletal disorders as well as other diseases may result. 
On the other hand, biological systems have developed a 
series of protective mechanisms against cadmium's toxic 
effects. At cellular or molecular levels, these mechanisms 
may involve decreased cadmium uptake and its intracellular 
accumulation or an increased ability for the synthesis of 
cadmium-binding ligands. These ligands chelate or bind 
cadmium in a non-toxic or less toxic state. 
Such a cadmium-binding protective function has been 
ascribed to metallothionein, which is a small molecular 
weight, sulfhydryl rich protein. Among its 61 amino acids, 
20 are cysteines. One metallothionein molecule can form two 
metal clusters, A and B. Cluster A can bind 4 gram atoms of 
r 
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metal and cluster B can bind 3 gram atoms of metal; that is, 
one mole of metallothionein can bind 7 gram atoms of 
cadmium. 
Cellular levels of metallothionein are generally low, 
but these levels can increase dramatically in some cells 
upon stimulation by cadmium or zinc. In some of the cadmium 
resistant variants of CHO cells, relative cadmium resistance 
is determined by the rate of metallothionein synthesis. 
However, several lines of evidence suggest that this is not 
the only intracellular mechanism for protection against 
cadmium. 
Human lung carcinoma A549 cells are much more cadmium 
resistant than most other human tumor cells. However, these 
cells do not have correspondingly enhanced metallothionein 
synthesis in response to cadmium and have a comparable rate 
of cadmium uptake. This indicates that factors other than 
metallothionein synthesis and cadmium accumulation rates may 
be determinative in cadmium cytoprotective response in the 
A549 cells. 
Previous studies have shown that the A549 cells have a 
much higher level of cellular glutathione than that of 
normal and most other tumor cells. Glutathione is the most 
important cellular non-protein sulfhydryl compound. It 
participates in a number of significant cellular processes 
including: 1) transport of Y-glutamyl amino acids through 
the Y'-glutamyl cycle; 2) removal of hydroperoxides; 3) 
protection from ionizing radiation and heat shock; 4) 
complex formation with xenobiotic or endogenous reactive 
compounds, aiding in their detoxification and/or excretion; 
5) maintenance of the sulfhydryl status of proteins; 6) 
providing reducing power for the synthesis of 
nacromolecules; and, possibly, 7) regulation of cell growth. 
The major questions addressed in this thesis are whether 
glutathione is importantly involved also in cadmium 
cytoprotection and, if so, by what mechanism(s). 
EXPLANATION OF DISSERTATION FORMAT 
This dissertation is written in the alternate format. 
The sections of this dissertation are modified manuscripts 
that have been published or submitted for publication in 
the following journals: Cell Biology and Toxicology, 
Toxicology, and In Vitro Toxicology, a Journal of Molecular 
and Cellular Toxicology. Each section has its own 
abstract, introduction, materials and methods, results, 
discussion, acknowledgements, and references. Following 
these five sections is a general discussion of the entire 
dissertation. 
L__ 
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SECTION 1: EFFECT OF CELLULAR GLUTATHIONE DEPLETION ON 
CADMIUM-INDUCED CYTOTOXICITY IN HUMAN LUNG 
CARCINOMA CELLS 
^ . é .  
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EFFECT OF CELLULAR GLUTATHIONE DEPLETION ON 
CADMIUM-INDUCED CYTOTOXICITY IN HUMAN LUNG CARCINOMA CELLS 
Yu-Jian Kang 
M. Duane Enger 
Department of Zoology 
Iowa State University 
Ames, Iowa 50011 
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ABSTRACT 
The effect of glutathione (GSH) depletion on cellular 
Cd**-cytotoxlc response was Investigated in a subpopulation 
(T27) of human lung carcinoma A549 cells with coordinately 
high GSH levels and Cd**-reslstance. Cellular GSH levels 
were depleted by exposing the cells to diethyl maleate (DEM) 
or buthionine sulfoximine (BSO). Depletion of A549-T27 
cellular GSH by DEM or BSO was found to be dose-dependent. 
4-hour exposure of the cells to 0.5 mM DEM and 8-hour 
exposure to 10 mM BSO depleted 75-85% and 70-80% of total 
cellular GSH, respectively. The Cd**-cytotoxic response of 
non-drug treated A549-T27 cells is characterized by a 
threshold of 5 uM Cd** and an LDgg of 31 uM Cd**. 
Pretreatment with 0.5 mM DEM for 4 hours or with 10 mM BSO 
for 8 hours eliminated the threshold for Cd^^ cytotoxic 
effect and decreased the LDgg to 15 UM or 21 UM, 
respectively. Cells that were pretreated with 0.5 mM DEM or 
10 mM BSO and then exposed to these same concentrations of 
DEM or BSO during the subsequent assay for colony forming 
efficiency produced no colonies, reflecting an enhanced 
sensitivity to these agents at low cell density. DEM was 
found to be more cytotoxic than BSO. Synergistic cytotoxic 
effects were observed in the response of DEM pretreated 
8 
cells exposed to Cd**. 
The results demonstrated that depletion of most 
cellular GSH in A549-T27 cells prior to Cd** exposure 
sensitizes them to cadmium's cytotoxic effects. GSH thus 
may be involved in modulating the early cellular Cd** 
cytotoxic response. Comparison of reduced GSH levels and of 
Cd** cytotoxic responses in BSO-treated A549-T27 cells with 
those levels in other, untreated normal and tumor-derived 
cells suggests that the higher level of GSH in A549-T27 is 
not the sole determinant of its higher level of cd** 
resistance. 
INTRODUCTION 
Glutathione (GSH) is important in cellular 
detoxification of xenobiotics (Ketterer, 1982) and in the 
regulation of cellular thiol-disulfide status (Reed, 1984). 
The level of cellular GSH can alter the cytotoxicity of many 
chemicals (DeGraff and Mitchell, 1985; Russo et al., 1986; 
Roizin-Towle, 1985), as well as of physical agents such as 
heat (Freeman et al., 1985; Russo et al., 1984) and 
radiation (Mitchell et al., 1983a; Russo and Mitchell, 
1984). 
Selective modulation of cellular GSH has been used for 
studying the relationship between GSH levels and cellular 
thermal sensitivity and thermotolerance, as well as in 
studies directed toward effecting differential responses of 
normal and tumor cells to chemotherapeutic drugs. There is 
increasing evidence that thermotolerance induction parallels 
GSH elevation and thermosensitization can be induced by GSH 
depletion (Mitchell et al., 1983b; Freeman et al., 1985; 
Shrieve et al., 1986). Treatment of cells with 
L-2-oxothiazolidine-4-carboxylate (OTZ) or buthionine 
sulfoximine (BSO) respectively can differentially increase 
or decrease cellular GSH content of normal and tumor cells, 
resulting in differential response to drugs used in 
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chemotherapy (Russo et al., 1986). 
Studies on human lung carcinoma-derived line A549 cells 
have shown that the A549 cells are markedly Cd^^ resistant 
relative to normal human fibroblasts and to many other human 
tumor cells (Enger et al., 1986a). These cells also have a 
much higher level of cellular GSH than that of normal and 
most other tumor cells (Brodie and Reed, 1985). It is 
possible that the relatively high GSH level observed in the 
A549 cells is one of the factors responsible for the high 
Cd** resistance of these cells. 
The GSH level of A549 cells can readily be reduced by 
BSO, through its inhibition of GSH biosynthesis, or by 
diethylmaleate (DEM), through its conjugation with GSH 
(Brodie and Reed, 1985; Meister, 1985). However, no study 
on the changes of Cd** cytotoxic response after such GSH 
depletion has been reported. Because such an approach would 
greatly assist efforts to elucidate the role of GSH in 
cellular cadmium responses, the present investigation to 
determine the effect of depletion of cellular GSH on 
Cd^"*"-induced cytotoxicity was undertaken. A549 cells were 
chosen as the target population because their coordinately 
high levels of GSH and Cd** resistance suggest a causal 
relationship that can be probed by this approach. 
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MATERIALS AND METHODS 
Cells and cell culturlna conditions 
A Cd**-resistant subpopulation, designated as T27, of 
human lung carcinoma derived line A549 cells (obtained from 
Dr. Harold Moses at the Mayo Clinic and Foundation) was 
routinely grown in McCoy's 5A medium supplemented with 10% 
fetal calf serum (HyClone), 2.2 g/L of sodium bicarbonate 
and antibiotics. The cells were maintained at 37°c and pH 
7.0-7.2 in a humidified atmosphere of 95% air and 5% COg. 
Stock cultures were passaged at 3-4 day intervals. Clones 
were established as described (Enger et al., 1986a) by J. G. 
Tesmer at Los Alamos National Lab. Tests for mycoplasma 
were negative. Cells for each experiment were removed from 
stock cultures with trypsin-EDTA, counted with a Coulter 
counter, plated in 60-mm^ round Petri cell culture dishes or 
25-cm^ tissue culture flasks at 0.5 x 10® cells/dish or 
flask, and pre-incubated at the same conditions as used in 
maintaining stock cultures for 24 hours prior to each 
experiment. 
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Depletion of cellular GSH 
DEM, purchased from Aldrich, was dissolved in dimethyl 
sulfoxide (DHSO) and then diluted with glucose-free Hank's 
balanced salt solution (HBSS). The final concentration of 
DEM/DMSO added was 0.1 mM or 0.5 mM DEM and 0.5 mM DMSO. 
DL-buthionine-(R,S)-sulfoximine (BSO, Chemalog) was also 
dissolved in glucose-free HBSS. The final concentration of 
BSO after addition to experimental cultures was 0.1 mM or 10 
mM. Cells, removed from stock cultures and pre-incubated as 
described above, were exposed to DEM/DMSO or BSO in the 
desired concentrations by directly adding the drugs to the 
culture dishes. Cells not exposed to DEM/DMSO or BSO were 
exposed either to 0.5 mM DMSO or to HBSS as a control. The 
cells were then incubated under the same conditions as were 
stock cultures. The time-course of cellular GSH depletion 
was determined by GSH assay at one hour intervals for 5 
hours for DEM/DMSO treated cells, and at two hour intervals 
for 10 hours for BSO treated cells. 
Besides measurement of kinetic changes of cellular GSH 
depletion, dose-response of cellular GSH level to DEM/DMSO 
or BSO was determined after exposing the A549 cells to 
different concentrations of DEM/DMSO or BSO for 4 or 8 
hours, respectively. 
13 
Cd^cvtotoxlcltv measurement 
Cells, plated in 25-cmf tissue culture flasks and 
pre-incubated for 24 hours, were exposed to 0.5 mM DEM/0.5 
mM DMSO for 4 hours, or 10 mM BSO for 8 hours. Medium in 
the drug-treated and non-treated flasks was removed after 
drug exposure. The cells in the flasks were washed twice 
with pre-warmed phosphate buffered saline (PBS) and 
trypsinized with trypsin-EDTA. The cells were then counted. 
400 to 500 cells were seeded into 60-mm^ petri dishes 
containing pre-warmed 10% PCS medium and different 
concentrations of Cd** (0, 2.5, 5, 10^ 20, 40 uM) in a total 
volume of 6 ml. In some instances, 0.5 mM DEM/0.5 mM DMSO 
or 10 mM BSO was also present. Triplicate cultures were 
used for each treatment. The seeded cells were then 
incubated 10 days for colony formation. 
Another experimental protocol involved plating 400-500 
cells in 60 mm dishes for 12 hours prior to exposing them 
to 0.5 mM DEM/0.5 mM DMSO for 4 hours or 10 mM BSO for 8 
hours. After exposure to drugs, the medium was removed, the 
cells were washed twice with pre-warmed PBS and fresh medium 
with 5 uM Cd was added to each dish. Again, cultures were 
incubated 10 days prior to determination of colony 
formation. 
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To guàntitate the Cd"""*" cytotoxic effect due to 
different cell treatments, colonies were counted and the 
LDgg of each treatment was calculated. The colony formation 
efficiency of control cells was found to be 47.6 ± 3.5%. 
qgH seeay 
GSH levels in drug-treated and untreated cells were 
measured by the DTNB-GSSG reductase recycling assay 
(Anderson, 1985). Briefly, the cells were trypsinized, 
rinsed with cold PBS, centrifuged at 4°C, resuspended in 
cold 5% sulfosalicylic acid, vortexed, and recentrifuged. 
The supernatant was then assayed for GSH and GSSG content by 
measuring the change in color of DTNB at 412 nM in the 
presence of GSH reductase (Sigma) and NADPH (Sigma). The 
GSH level of control cells was found to be 30.7 + 3.6 
nmol/10^ cells. 
Determination of DEM or BSO cytotoxic effect 
Cells that had been pre-incubated in 25-cmf culture 
flasks for 24 hours were trypsinized and seeded in 60-mm^ 
petri dishes at 1.8 x 10^ cells/dish prior to exposure to 
15 
0.1 mM and 10 mM BSO or 0.25 mM and 0.5 mM DEM/0.5 mM DMSO. 
The cultures were then Incubated for 72 hours and inhibitory 
effects of DEM or BSO on cell growth were determined by 
counting the total number of cells in each dish at 24-hour 
intervals. 
gtatiBtical analvsig 
All results are presented as the mean ± SD. Data were 
initially compared by analysis of variance. When the 
analysis indicated a significant difference, Dunnett's test 
and Duncan's multiple-range test were used to determine 
specific effects (Bruning and Kintz, 1977). Data presented 
in Fig. 5 were analyzed by a simple linear regression model 
(Zar, 1984). LD50 values were extracted from the line best 
fitted to data points. Extrapolation of this line to 100% 
survival yielded the threshold values when such existed. 
Differences were considered to be significant when P < 0.05 
or P < 0.01. 
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RESULTS 
The GSH level of A549-T27 cells was reduced as a 
function of time exposed to DEM as illustrated in Figure 1. 
Sharply decreased GSH levels were observed after the first 
hour's exposure to both 0.1 mM DEM/0.5 mM DMSO and 0.5 mM 
DEM/0.5 mM DMSO. The cellular GSH level remained relatively 
constant during the next four hour's exposure to 0.1 mM 
DEM/0.5 mM DMSO. It continued to decrease throughout the 
five hour period in cells exposed to 0.5 mM DEM/0.5 mM DMSO; 
5-10% of the original GSH level was present after 5 hours. 
When GSH synthesis was inhibited by BSO, the cellular GSH 
level was also depleted as a function of time (Figure 2). 
The cellular GSH level was not reduced significantly by 0.01 
mM BSO during the first two hour's exposure. Thereafter, 
the level decreased slightly to approximately 80% of its 
original level and maintained at that level for several 
hours. Cells exposed to 10 mM BSO showed a marked decrease 
in cellular GSH level. Respectively, 20-30% and 15-25% of 
the initial GSH content was present after 8 hour and 10 hour 
exposure to 10 mM BSO. This result compares well with that 
reported by Russo et al. (1986). 
Depletion of the cellular GSH level by DEN or BSO as a 
function of dose is shown in Figures 3 and 4. Decrease in 
* 
Figure 1. Depletion of cellular GSH as a function of time 
exposed to DEM. A549-T27 cells were exposed to 
0.5 mM DHSO ( #—# ) , 0.1 mH DEM/0.5 mM I»1S0 
( •—•) or 0.5 mH DEM/0.5 mM DMSO (•—•), and 
GSH levels were measured at 1-hour intervals for 
5 hours. Values are means ± SD from triplicate 
samples 
GSH Concentration ( % of Control ) 
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Figure 2. Depletion of cellular GSH level as a function of 
time exposed to BSO. A549-T27 cells were exposed 
to HBSS ( 0—0), 0.01 mH BSO ( g—g ) or 10 mH 
BSO ( A—A ). GSH levels were measured at 2-hour 
intervals for 10 hours. Values are presented as 
means + SD from triplicate samples 
GSH Concentration ( % of Control ) 
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Figure 3. Depletion of cellular GSH levels in A549-T27 
cells, exposed to DEM foe 4 hours, as a function 
of DEM concentration. Percent of control values 
are given as means + SD (* P < 0.01) 
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Figure 4. Depletion of cellular GSH levels in A549-T27 
cells as a function of BSO concentrations to 
which the cells were exposed for 8 hours. Values 
presented are means ± SD (* P < 0.01) 
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GSH was found to be linearly related to the concentration of 
DEM to which the cells were exposed for 4 hours (Figure 3). 
At DEM concentrations of 0.1 %dM and 0.5 inM, the cellular GSH 
level was 15-25% and 70-80% depleted, respectively. These 
results accord with those presented in Figure 1. A 
concentration dependent response of cellular GSH depletion 
by BSO inhibition of GSH synthesis was also observed (Figure 
4). The cellular GSH level was reduced to about 20-30% of 
its initial value in the cells exposed to 10 mM BSO for 8 
hours, a result which compares well with that shown in 
Figure 2. 
Reducing the cellular GSH level sensitized A549 cells 
to Cd^^. Untreated A549-T27 cells have a Cd^^ cytotoxic 
theshold of 5 uH Cd** and an LDgQ of 31 uM (Figure 5A). Two 
changes were observed in the Cd^^ cytotoxic response of the 
cells in which cellular GSH was reduced by BSO or DEM 
(Figure 5B and 5C). First, the threshold for Cd** cytotoxic 
response disappeared. Second, LDg^ values for Cd** 
cytotoxicity were reduced. The LDg^ for 8-hour, 10 mM BSO 
pre-treated cells is approximately 21 uM Cd**, and for 
4-hour, 0.5 mM DEM pre-treated cells, about 15 uM Cd^*. The 
respective GSH levels are 20-30% and 15-25% of the normal 
value. 
Cells that were both pre-treated and concurrently 
exposed to 0.5 mM DEM or 10 mM BSO produced no colonies. 
26 
Even in control cells, which were only pre- and concurrently 
exposed to DEM or BSO and were not exposed to Cd^*, no 
colonies formed. 
Cells pre-treated with different concentrations of DEM 
for 4 hours and subsequently exposed to 5 uM Cd**"^ without 
DEM showed a pattern of survival as a function of DEM 
concentration as shown in Figure 6. A slight decrease in 
survival of the cells cultured in 5 uM Cd** was observed at 
0.2 mM DEM. At 0.4 mM DEM a significant decrease occurred. 
The GSH level is 20-30% of its initial value in 0.4 mM DEM 
pretreated cells. 
Eight-hour BSO pretreated cells cultured in 5 UM Cd** 
showed a BSO dose response similar to that of cells 
pretreated with DEM (Figure 7). In this instance, a 
significant Cd cytotoxic response occurred at a BSO 
concentration of 10 mM, which results in diminution of GSH 
to 20-30% of its initial value. Although GSH levels in 4 
hour, 0.4 mM DEM and 8 hour, 10 mM BSO pretreated cells were 
70-80% depleted in both instances, Cd** cytotoxic response 
significantly differed between the two treatments (p < 
0.05). 
As shown in Table 1, no toxic response was observed in 
cells exposed to either 0.1 mM or 10 mM BSO. However, 
significant toxic response was observed in cells treated 
with either 0.25 or 0.5 mM DEM. Exposure of the cells to 
27 
either 0.25 mM or 0.5 mM OEM for 24 hours decreased the cell 
number to half that of the control. Exposure of the cells 
to 0.25 mM or 0.5 mM DEM for 48 hours decreased the cell 
number to 1/4 and 1/8 that of control, respectively. After 
72 hours, the control cells had doubled their number. The 
DEM-treated cells, however, did not change in number between 
48 and 72 hours. Cells treated with 0.5 mM DMSO alone did 
not respond differently from controls. 
* 
Figure 5. Cd^^-cytotoxic response of A549-T27 cells. A. 
Untreated cells; the Cd"*"*' cytotoxic response is 
characterized by a threshold of 5 uN Cd^^ and an 
LDgQ of 31 uM. B. Eight-hour, 10 mN BSO 
pretreated cells (GSH levels are 20-30% of their 
original level); the threshold is eliminated and 
the LDgQ is reduced to 21 uM Cd^^. 
C. Four-hour, 0.5 nH DEM/0.5 mM DMSO pretreated 
cells (GSH levels are reduced to 15-25% of 
control); LDg^ is now 15 uM Cd^^ and no threshold 
for cytotoxic response is observed. There is a 
significant difference between the cytotoxic 
response of A and that of B and C (P < 0.01), 
and between the response of B and that of C 
(P < 0.05) 
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Figure 6. Modulation of Cd**-cytotoxic response of A549-T27 
cells by DEM pretreatment. Cells were pretreated 
with different concentrations of DEM for 4-hours 
and then exposed to 5 uM Cd"*"*". Values are 
means + SD (** P < 0.01) 
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Table 1. Effects of BSO and DEM on cell growth* 
Treatment 24-hour 48-hour 72-hour 
Control 21.4 ± 1.6 23.3 ± o
 
vo
 
51.4 ± 0.5 
0.1 mM BSO 24.3 + 2.3 23.1 ± 1.2 53.6 ± 0.6 
10 mM BSO 22.2 ± 2.0 24.7 ± 0;6 56.4 ± 0.1 
0.25 mM DEM 11.9 ± 1.1 5.5 ± 0.3 5.6 ± 0.6 
0.50 mM DEM 11.5 + 0.9 2.8 ± 0.1 2.9 ± 0.2 
^Human lung carcinoma A549-T27 cells were exposed to 
different concentrations of BSO and DEM at a cell density of 
18 X 10^ cells/dish. The cells were then incubated at 37°C 
and counted at 24-hour intervals. (Values are means x 10^ + 
SO from triplicate samples.) 
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DISCUSSION 
Reduction of cellular GSH in A549-T27 cells via the 
different mechanisms involved in the actions of DEM and BSO 
in both instances sensitized the cells to Cd . Most 
4*4* importantly, the threshold for Cd cytotoxic response was 
diminished, from 5 uM to zero or a value too low to be 
measured. This result shows that GSH plays an important 
role in the cellular protective mechanisms involved in the 
•4-+ Cd cytotoxic response. 
In the present study, we pre-treated A549-T27 cells 
with either DEM or BSO to reduce cellular GSH to a low level 
just before exposing the cells to Cd**. Cells will 
resynthesize GSH after depletion through feedback control 
mechanisms (Meister, 1985; Richman and Meister, 1975). A549 
cells can resynthesize GSH very effectively after depletion 
by DEM when provided with the appropriate sulfur-containing 
precursor amino acid (Brodie and Reed, 1985). Also, cells 
will increase their GSH levels in response to Cd** (Seagrave 
et al., 1983). The observed Cd** sensitization of the cells 
that were pretreated only with DEM or BSO thus suggests that 
GSH is most likely involved in initial resistance to 
Cd**-cytotoxicity. 
Important to interpretation of these studies on the 
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relationship of GSH levels to Cd''"*" cytotoxic response is the 
specificity and toxicity of the drugs used to lower GSH. 
The use of DEM occasions obvious problems. At the DEM doses 
and cell densities used, DEM itself markedly affects cell 
growth (Table 1). Also, when DEM pretreated cells were 
exposed to Cd**, there was a greater increase in 
Cd**-cytotoxic response than that which occurred in cells 
pretreated with BSO to effect approximately the same reduced 
GSH level (Figure 5, 6 and 7). Since there was no effect of 
DEM pretreatment on the colony formation efficiency, it 
appears that synergistic cytotoxic effects are involved in 
the Cd** response of the DEM pretreated cells. 
BSO is more specific in its action than DEM (Meister, 
1985). It apparently affects primarily 7^-glutamylcysteine 
synthetase, which catalyzes the first step in GSH synthesis. 
Such a mechanism would be expected not to elicit toxic 
responses other than those due indirectly to lowered GSH 
levels. In accord with this prediction, we observed no 
effects on cell growth at the doses of BSO used (Table 1), 
and no diminution in colony formation by BSO pre-treated 
cells. However, when cells were exposed continuously to BSO 
at the low cell density used in quantitating colony 
formation (400-500 cells/dish), no colonies formed. We 
conclude that BSO has an inhibitory effect on cell growth 
which is cell density dependent. Whether this inhibitory 
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effect of BSO on low-density cell growth is indirect, 
involving a reduction in GSH and thereby a reduction in 
cellular stress resistance, or whether GSH levels play a 
direct role in regulation of cellular proliferation needs to 
be further investigated. The fact that 5 mM BSO 
dramatically reduces cysteine uptake in A549 (Brodie and 
Reed, 1985) indicates that there is at least one mechanism 
by which BSO may produce adverse effects in cell growth and 
viability other than via reduced GSH. 
Although the present study shows that reduction of 
cellular GSH sensitizes the A549 cells to Cd^^ cytotoxicity, 
we cannot conclude that their relatively high Cd** 
resistance is due entirely to their concomitantly higher 
cellular GSH level. When the cellular GSH level in the A549 
cells was 70-80% depleted, it attained a level similar to 
that of untreated human tumor A204 and AlOl 0 cells (Enger 
et al., 1984). However, the resistance of the A549 cells to 
Cd"*"*" cytotoxicity still remained much higher than that of 
the A204 and AlOl D cells, which have LD^^'s of 1.4 and 0.2 
uM Cd**, respectively (Enger et al., 1986a). Previous 
studies showed that the difference in Cd"*"^ resistance 
between A549 and other tumor and normal cells is not due to 
a difference in HT synthesis. Also, increased Cd** uptake 
is not responsible for the sensitivity of A204 relative to 
A549. (Enger et al., 1986a). This suggests that mechanisms 
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Other than those involving Cd** uptake, netallothionein 
synthesis or initial 6SH levels may be involved in the 
Cd^^-cytotoxic resistant response of the A549 cells. 
As noted above, the Cd**-cytotoxic threshold of 
A549-T27 cells disappeared when GSH levels were 70-80% 
depleted. This suggests that the threshold may be due to a 
high initial GSH level. The level of cytotoxic response 
after the first hour or two of Cd^^ exposure will depend in 
part on the rapidity of induced MT synthesis (Enger et al. 
1986b). It may also depend on the kinetics of Cd**-induced 
GSH synthesis. Seagrave et al. (1983) treated different 
Cd^^-resistant variants of Chinese hamster ovary (CHO) cells 
with maximal subtoxic levels of CdClg and observed that the 
kinetics of cellular GSH changes involved eventual increases 
in GSH content in all variant populations. Their results 
further suggested that differential kinetics of Cd*^"^-induced 
changes in GSH levels may play a role in differential 
cytotoxic response. That is, a variant more resistant to 
Cd** than predicted on the basis of its metallothionein 
synthesis response did not show the initially reduced GSH in 
response to Cd** shown by the others. There is thus a 
possibility that GSH kinetics may be one factor responsible 
for the high Cd"*"^ resistance of A549 cells. 
39 
ACKNOWLEDGEMENTS 
This work was supported by NIEHS/PHS grant ES03863-02 
and by Iowa State University. We thank Patricia Jenkins for 
valuable technical support and Mary Nims for manuscript 
preparation. 
40 
REFERENCES 
Anderson, M. E. 1985. Determination of glutathione and 
glutathione disulfide in biological samples. Methods 
Enzymol. 113:548-555. 
Brodie, A. E. and Reed, D. J. 1985. Buthionine sulfoximine 
inhibition of cystine uptake and glutathione biosynthesis in 
human lung carcinoma cells. Toxicol. Appl. Pharmacol. 
77:381-387. 
Bruning, J. L. and Kintz, B. L. 1977. Computational 
Handbook of Statistics. Scott, Foresman and Company, 
Glenview, Illinois. 
DeGraff, W. G. and Mitchell, J. B. 1985. Glutathione 
dependence of neocarzinostatin cytotoxicity and mutagenicity 
in Chinese hamster V-79 cells. Cancer Res. 45:4760-4762. 
Enger, M. D., Hildebrand, C. E., Walters, R. A., Seagrave, 
JC, Barham, S. S. and Hoaglund, H. C. 1984. Molecular and 
somatic cell genetic analysis of metal resistance mechanisms 
in mammalian cells. Pp. 38-62. In A. H. Tashjian, ed. 
Molecular and Cellular Approaches to Understanding 
41 
Mechanisms of Toxicity. Harvard School of Public Health, 
Boston. 
Enger, M. D., Tesmer, J. G., Travis, G. L. and Barham, S. S. 
1986a. Clonal variation of cadmium response in human tumor 
cell lines. Am. J. Physiol. 250 (Cell Physiol. 19): 
C256-C263. 
Enger, M. D., Hildebrand, c. E., Seagrave, JC. and Tobey, R. 
A. 1986b. Cellular resistance to cadmium. Pp. 363-396. In 
E. C. Foulkes, ed. Handbook of Experimental Pharmacology. 
Vol. 80. Springer-Verlag, Berlin. 
Freeman, M. L., Malcolm, A. W. and Meredith, J. J. 1985. 
Role of glutathione in cell survival after hyperthermic 
treatment of Chinese hamster ovary cells. Cancer Res. 
45:6308-6313. 
Ketterer, B. 1982. The role of nonenzymatic reactions of 
glutathione in xenobiotic metabolism. Drug Metabol. Rev. 
13(1):161-187. 
Meister, A. 1985. Methods for the selective modification 
of glutathione metabolism and study of glutathione 
transport. Methods Enzymol. 113:571-585. 
42 
Mitchell, J. B., Russe, A., Kinsella, T. J. and Glatstein, 
E. 1983a. Glutathione elevation during thernotolerance 
induction and thermosensitization by glutathione depletion. 
Cancer Res. 43:987-991. 
Mitchell, J. B., Russo, A., Bigalow, J. E. and HcPherson, S. 
1983b. Cellular glutathione depletion by diethyl maleate or 
buthionine sulfoximine: No effect of glutathione depletion 
on the oxygen enhancement ratio. Radiat. Res. 96:422-428. 
Reed, D. J. 1984. Cellular defense mechanisms against 
reactive metabolites. In M. W. Anders, ed. Bioactivation 
of Foreign Compounds. Academic Press, New York. 
Richman, P. 6. and Meister, A. 1975. Regulation of 
y-glutamyl-cysteine synthesis by nonallosteric feedback 
inhibition by glutathione. J. Biol. Chem. 250:1422-1426. 
Roizin-Towle, L. 1985. Selective enhancement of hypoxic 
cell killing by melphalan via thiol depletion: in vitro 
studies with hypoxic cell sensitizers and buthionine 
sulfoximine. J. Natl. Cancer Inst. 74:151-157. 
Russo, A., Mitchell, J. B. and McPherson, S. 1984. The 
43 
effects of glutathione depletion on thermotolerance and 
heat. Stress protein synthesis. Br. J. Cancer 49:753-758. 
Russo, A. and Mitchell, J. B. 1984. Radiation response of 
Chinese hamster cells after elevation of intracellular 
glutathione levels. Int. J. Radiat. Oncol. Biol. Phys. 
10:1243-1247. 
Russo, A., DeGraff, W., Friedman, N. and Mitchell, J. B. 
1986. Selective modulation of glutathione levels in human 
normal versus tumor cells and subsequent differential 
response to Chemotherapeutic drugs. Cancer Res. 
46:2845-2848. 
Seagrave, JC., Hlldebrand, C. E. and Enger, M. D. 1983. 
Effects of cadmium on glutathione metabolism in cadmium 
sensitive and cadmium resistant Chinese hamster cell lines. 
Toxicology 29:101-107. 
Shrleve, D. L., Li, 6. C., Astromoff, A. and Harris, J. 
1986. Cellular glutathione, thermal sensitivity, and 
thermotolerance in Chinese hamster fibroblasts and their 
heat-resistant variants. Cancer Res. 46:1684-1685. 
44 
Zar, J. H. 1984. Biostatlstlcal analysis. Prentice-Hall, 
Inc., Englewood Cliffs, New Jersey. 
4 
*. 
45 
SECTION 2: GLUTATHIONE IS INVOLVED IN THE EARLY 
CADMIUM CYTOTOXIC RESPONSE IN HUMAN 
LUNG CARCINOMA CELLS 
46 
GLUTATHIONE IS INVOLVED IN THE EARLY CADMIUM 
CYTOTOXIC RESPONSE IN HUMAN LUNG CARCINOMA CELLS 
Yu-Jian Kang 
M. Duane Enger 
Department of Zoology 
Iowa State University 
Ames, Iowa 50011 
47 
ABSTRACT 
Depletion of cellular glutathione (GSH) has been shown 
to sensitize A549-T27 human tumor cells to the cytotoxic 
effects of Cd"*"*". In this study the temporal and 
quantitative relationships between reduced cellular GSH 
levels and cadmium cytotoxic response in these cells were 
further investigated. Exposure of A549-T27 cells to 10 mM 
buthionine sulfoximine (BSO) for 8 hours decreased their GSH 
level by 65%. This GSH level remained relatively constant 
for eight hours in the presence or absence of BSO, but 
recovered to 83% of the normal cellular level 24 hr after 
removal of BSO. Exposure to 5 uM Cd^^ for 8 hours did not 
significantly change cellular GSH levels. 
Pretreatment of the A549-T27 cells with 10 mM BSO for 8 
hours and subsequent exposure of the cells to Cd** for 10 
days, with or without concurrent treatment of 10 mM BSO 
during the first 8 hours of Cd** exposure, resulted in 
disappearance of the 5 uM Cd** threshold for cytotoxic 
response and reduction of the LCgg from 31 uM Cd** to 21 uM. 
Similar results were obtained when BSO pretreated cells were 
exposed to Cd** for 8 hours. The threshold for cytotoxic 
response of 10 uM Cd"^"*" disappeared and the LCgg was reduced 
from 60 uM to 29 uM Cd** (with concurrent BSO treatment) and 
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30 uM (BSO pretreatnent only). The results show that GSH 
plays an important role in early cellular protective 
responses to Cd"*"*". 
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INTRODUCTION 
Glutathione (GSH) is involved in molecular protective 
mechanisms that modulate cellular responses to radiation 
(Biaglow and Varves, 1983; Russo and Mitchell, 1984), heat 
(Freeman et al., 1985; Russo et al., 1984), toxic chemicals 
(DeGraff and Mitchell, 1985; Ketterer, 1982) and their 
reactive metabolic intermediates (Arrick and Nathan, 1984). 
Human lung carcinoma-derived A549 cells are markedly Cd"*"*" 
resistant relative to normal human fibroblasts and most 
other human tumor cells (Enger et al., 1986). Coordinately, 
A549 cells have a several-fold higher level of cellular GSH 
than most other cells (Brodie and Reed, 1985; Enger et al., 
1985; Russo et al., 1986). To determine if there is a 
causal relationship between the high GSH level in A549 and 
their high resistance to Cd^*, we have studied the effect of 
cellular GSH depletion on Cd**-induced cytotoxicity in a 
relatively Cd** resistant subpopulation (T27). This clone 
is characterized by a cytotoxic response threshold of 5 uM 
Cd^* and an LCg^ of 31 uM (Kang and Enger, 1987). 
Pretreating T27 cells with 10 mM buthionine sulfoximine 
(BSO) for 8 hours depleted their cellular GSH level 70-80% 
and caused a complete disappearance of the threshold for 
Cd'*"*' cytotoxic response and reduction of the value for 
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Cd**. The results showed that GSH levels existing at the 
beginning of Cd exposure modulate the cellular response to 
Cd++. 
The BSO sensitization of the T27 cells to Cd** Involved 
reducing cellular GSH to a known level prior to the addition 
of Cd**. However, the GSH level recovered at an undefined 
rate during the period of Cd** exposure. Some cells 
increase their cellular GSH level upon being stimulated by 
Cd** (Brodie and Reed, 1985) but whether such effect 
occurred in the Cd** exposed A549-T27 cells was not 
determined. To more precisely define the temporal ' 
relationships between reduced GSH levels and the cytotoxic 
response of A549-T27 cells to Cd** exposure, we investigated 
cell survival following short term Cd** exposure at known 
GSH levels. 
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MATERIALS AND METHODS 
Cells and cell culturinq conditions 
A relatively Cd** resistant subpopulation, T27, was 
cloned from human lung carcinoma-derived A549 cells obtained 
from Dr. Harold Moses at the Mayo Clinic and Foundation. 
The cells were routinely grown in McCoy's 5A medium 
supplemented with 10% fetal calf serum (HyClone), 2.2 g/L of 
sodium bicarbonate and antibiotics. They were maintained at 
37°c and pH 7.0-7.2 in a humidified atmosphere of 95% air 
and 5%. COg. Stock cultures were passaged at 3-4 day 
intervals. Clones were established as described (Enger et 
al., 1986). Tests for mycoplasma were negative. Prior to 
each experiment cells were removed from stock cultures with 
trypsin-EDTA, counted with a Coulter counter, plated in 60 
mm^ culture dishes or 25-cm? tissue culture flasks at a cell 
density of 0.5 x 10^ cells/dish or flask and pre-incubated 
16 hr under the same conditions used in maintaining stock 
cultures. This was done to ensure that cells would be at 
the same density and growth stage in each experiment. 
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Kinetic changes in cellular GSH 
Cells were exposed to 10 mM BSO (purchased from 
Chemalog) by direct addition of the agent dissolved in 
phosphate buffered saline (PBS). The cells were then 
incubated under the same conditions as were the stock 
cultures. The time-course of cellular GSH kinetic changes 
was determined by measuring the GSH content at 2 hour 
intervals for 16 hours. Another protocol involved measuring 
the kinetic changes of cellular GSH at 2 hour intervals for 
8 hours after 8-hour exposure of the cells to 10 mM BSO. 
Briefly, after 8-hour exposure of the cells to 10 mM BSO, 
the medium was removed, the dishes were washed twice with 
37°c pre-warmed PBS and pre-warmed fresh medium was added to 
the dishes to continue the incubation. GSH content was then 
measured according to the designated schedule. In addition 
GSH levels were measured 16 hour and 24 hour after removal 
of BSO. Controls were exposed to the same volume of PBS as 
were BSO-treated cells. Triplicates were used for each 
treatment. 
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GSH assay 
GSH levels were determined as nmol/mg protein. GSH 
levels were measured by the DTNB-GSS6 reductase recycling 
assay (Anderson, 1985). Briefly, the cells were 
trypsinized, rinsed with cold PBS, centrifuged at 4°C, lysed 
with 10 mM hydrochloric acid, deproteinized with 
5-sulfosalicylic acid (5% final concentration), and 
recentrifuged. The supernatant was then assayed for GSH and 
GSSG content by measuring the change in color of DTNB at 412 
nm in the presence of GSH reductase (Sigma) and NADFH 
(Sigma). Protein content was measured using Bradford's 
method (Bradford, 1976) with an assay kit purchased from 
Bio-Rad Inc. The GSH level of control cells (at passage 13) 
was found to be 235 + 15 nmol/mg protein. 
Cd++-cvtotoxicitv determination 
For either long term (10 days Cd** exposure) or acute 
(8 hours Cd** exposure) Cd^* cytotoxicity determination, 
cells were seeded in 60-mm round tissue culture dishes 
containing pre-warmed 10% FCS McCoy's 5A medium and 
different concentrations of Cd**. After 10 days incubation 
for macroscopic colony formation, the plates were rinsed 
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with PBS and stained with crystal violet. Colonies were 
enumerated as a function of Cd concentrations. 
Statistical analysis 
Effects of BSO concentrations on cellular GSH levels 
were analyzed by analysis of variance (ANOVA). Pairwise 
comparison was used to analyze parallel experiments. 
Dunnett's multiple comparison test was employed to determine 
specific effects (Bruning and Kintz, 1977). Data for 
Cd**-cytotoxic-responses were analyzed by the simple linear 
regression model (Zar, 1984). LCg^ values were extracted 
from the line best fit to the data points. Differences were 
considered to be significant when P < 0.05. 
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RESULTS 
Cellular GSH levels decreased markedly following 
exposure to 10 mM BSO. After 8 hours, the GSH concentration 
was reduced to 35% of the Initial value. The time course of 
this reduction Is shown In Figure 1. The BSO-reduced 
cellular GSH level did not show a rapid recovery following 
BSO removal. Rather, depletion continued for several hours 
so that a level of about 25% of the normal value was 
attained 4 hours after BSO removal. This value Increased 
slightly during the next 4 hours (Figure 1). After BSO 
removal for 16 hours and 24 hours, the GSH levels recovered 
to 55% and 83% of the original level, respectively. As also 
shown In Figure 1, there Is no significant difference In GSH 
levels between cells only pretreated with BSO and those 
pretreated and maintained In 10 mM BSO during the next 8 
hours (P > 0.05). Changing the medium containing BSO 
(without removal of the drug) at 8 hours had little effect 
on GSH content compared with continuous BSO exposure (Figure 
1). 
Treatment with 5 uM Cd** resulted In no change In 
cellular GSH level during the first 2 hours of exposure, a 
slight (10%) decrease at 4 hours, which Is not significant, 
and a return to control values at 6 and 8 hours (Figure 2). 
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Cells that were pretreated with 10 mM BSO for 8 hours 
and then exposed to 5 uH Cd** with BSO present for an 
additional 8 hours showed a continuous decrease in 6SH to 7% 
of control (Figure 2). Cells only pretreated with BSO prior 
++ to exposure to 5 uM Cd showed a decrease in GSH level 
during the first 2 hours Cd** exposure to 20% of control. 
This level remained almost constant during the next 6 hours 
(Figure 2). similar responses were elicited by 10 uM Cd** 
(data not shown). 
As shown in Figure 3A, the Cd** cytotoxic response of 
A549- T27 cells is characterized by a threshold of 5 UM Cd** 
and an LCgg of 31 uM Cd**. Cells that were pretreated with 
10 mH BSO for 8 hours showed a different Cd** cytotoxic 
response (Figure 3B). The significant changes are that the 
Cd threshold disappeared and the LCgg was reduced from 31 
uM Cd** to 21 uM Cd**. Cells pre-treated with 10 mM BSO for 
8 hours displayed no difference in Cd** cytotoxic response 
from that of cells pretreated with 10 mM BSO prior to 
continuous Cd** challenge with 10 mM BSO present during 
first 8 hours (Figure 3B and 3C). In both protocols, Cd** 
exposure began at a GSH level 35% of control. This level 
was maintained, without significant difference between the 
two BSO protocols, at a relatively constant level during the 
first 8 hours of Cd** exposure (Figures 1 and 2). 
Acute Cd** cytotoxic response of the T27 cells is shown 
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in Figure 4A. Cells treated with Cd^^ for 8 hours, as 
opposed to continuous exposure, also showed a threshold in 
response, which is about 10 uM Cd**, and a higher LCg^ of 60 
uM Cd**. Cells pretreated with 10 mM BSO for 8 hours 
responded to 8 hours of Cd** exposure as shown in Figure 4B 
and 4C. Regardless of whether BSO was present during the 
time of Cd** exposure, the BSO pretreated cells were 
sensitized to such extent that the threshold for 
cytotoxicity disappeared and the LCg^ values were reduced. 
BSO pretreated cells exposed to Cd** for 8 hours and those 
exposed to both BSO and Cd** for 8 hours showed LCg^ values 
of 30 and 29 uM, respectively. Again, there was no 
significant difference in GSH levels during the time of Cd** 
exposure between the two BSO protocols. 
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Figure l. Reduction of cellular GSH concentration in 
A549-T27 cells as a function of 10 mH BSO 
exposure time. Cells were continuously exposed 
to 10 mH BSO (#-#). Alternatively, after 8 hours 
exposure BSO containing medium was replaced with 
fresh medium with ( H—0 ) or without ( ^ ) * 
BSO. There is no significant difference in GSH 
levels due to medium changes (P > 0.05) 
GSH Concentration ( % of Control ) 
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Figure 2. GSH levels as a function of time that A549-T27 
cells were stimulated with 5 uM CdClg. Cells 
were exposed to 5 uH CdCl^ only ( *-# ) or were 
pretreated with 10 mM BSO for 8 hours, then 
exposed to 5 UM CdCl^ without ( ^  ^  , or with 
( ^ ) 10 mM BSO. There is no significant 
difference in the responses of the cells to the 
two BSO protocols (P > 0.05) 
s 100 
a> 40 
2 4 6 
Time of Cadmium Exposure ( Hrs. ) 
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Figure 3. Effect of BSO treatment on cytotoxic 
response. Cells were exposed to the indicated 
++ [Cd ] throughout the period of colony formation 
(10 days). A, no BSO treatment; B, cells were 
pretreated with 10 mM BSO prior to Cd^^ exposure; 
c, cells were pretreated with 10 mM BSO and were 
exposed to that concentration of BSO also during 
the first 8 hours of Cd^^ exposure. There is a 
significant difference between the cytotoxic 
response of A and that of B and C (P < 0.01), but 
not between the response of B and that of C 
(P > 0.10) 
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Figure 4. Effect of reduced GSH concentration on the 
survival of cells exposed to different cadmium 
concentrations for eight hours. A, control; B, 
cells were pretreated with 10 mM BSO; C, cells 
were pretreated as in B but BSO exposure was 
continued throughout the eight hours of Cd** 
exposure. Significant difference exists between 
the cytotoxic response of A and that of B and C 
(P < 0.01), but not between the response of B and 
C (P > 0.10) 
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DISCUSSION 
Exposure of A549-T27 cells to BSO results in a 
pronounced decrease in GSH content. In cells treated with 
10 mM BSO for 8 hours, the GSH concentration is reduced to 
35% of that in untreated cells. Removal of BSO at this 
stage does not result in rapid renewal of GSH content. 
Rather, the reduced level remains essentially constant 
during the next 8 hours. A partial explanation for the lack 
of GSH repletion following removal of BSO is provided by its 
mechanism of action. BSO competes with L-glutamate for 
binding to the active site of T^glutamyl cysteine 
synthetase. Following phosphorylation of bound BSO, binding 
becomes essentially irreversible (Meister, 1985). A high 
level of BSO thus selectively and irreversibly inactivates 
the enzyme involved in the first step of GSH synthesis, the 
synthesis of T'-glutamy 1-cysteine. Removal of exogenous BSO 
would be expected to result in the reappearance of GSH 
synthesis as newly formed, active enzyme is synthesized. 
Evidently, however, the rate of reappearance of enzyme is 
sufficiently slow, and/or the amount of endogenous unbound 
BSO is large enough, that no significant T'-glutamyl-cysteine 
synthetase activity recurs for several hours following 8 
hours exposure to 10 mM BSO. This phenomenon provides a 
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convenient protocol for studying the effects of reduced 
cellular GSH content on cytotoxic response. When the 
cytotoxic agent is Cd^^, however, the possibility of 
Cd'*"**'-induced alterations in GSH synthesis must be 
considered. Seagrave et al. (1983) noted that Cd** exposure 
causes a pronounced increase in GSH content in CHO cells. 
The Cd^* induced increase in GSH in these cells occurs 
immediately after exposure and increases 2.5 times in twelve 
hours. In CHO Cd** resistant (Cd^) variants, the GSH level 
decreases within the first few hours exposure before 
increasing to a higher level. The initial decrease may be 
due to depletion of cysteine caused by rapid Cd** induced 
metallothionein (MT) synthesis. A549 cells synthesize MT at 
a rate comparable to that of cells with active but 
unamplified MT genes (unpublished observation to be reported 
elsewhere). The possibility thus exists for Cd** induced 
alterations in GSH levels in A549 by such an MT 
synthesis-mediated mechanism. As observed in this study, 
however, exposure to 5 uM Cd** results in only a slight and 
transient decrease in GSH in control cells, and in no 
significant change in GSH in BSO pretreated cells. This 
absence of an effect of Cd*^*^-induced MT synthesis on GSH 
levels is not without precedent. Wong and Klaassen (1981) 
showed that Zn** or Cd** induced MT synthesis in rat kidney 
and liver is not preceded by significant changes in GSH 
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levels. 
BSO-induced reduction In 6SH content sensitized 
A549-T27 cells to Cd**"** as indicated by the loss of an 
observable threshold concentration for cytotoxicity and a 
reduced LCgg. This occurred both when the BSO treated cells 
were exposed to Cd** for 8 hours during which GSH was 
maintained at a defined, reduced level and when Cd** 
exposure occurred throughout the period of colony formation. 
In the latter instance, GSH levels recover during the time 
of prolonged Cd** exposure. That this recovery in GSH 
content was without significant effect on cytotoxic response 
is indicated by the fact that long term survival was the 
same when BSO exposure was continued during the first 8 
hours of Cd** exposure as when the cells were BSO pretreated 
only. These protocols result in slightly different GSH 
levels 8 hours after Cd"*"*" exposure. However, GSH recovery 
would lag by 8 hours in cells with prolonged BSO treatment. 
Such a lag in GSH recovery caused no difference in Cd** 
cytotoxic response, indicating that the level of GSH 
existing during the initial period of Cd** exposure is of 
greatest importance in modulating cytotoxic response. 
That a reduced level of GSH during acute Cd*^ exposure 
accounts for most of the observed sensitization was 
confirmed by experiments employing 8 hour Cd*^^ exposure of 
cells pretreated only, or pretreated and also concurrently 
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treated, with BSO. These BSC treatment protocols result in 
similarly reduced GSH levels during the first 6 hours of 
Cd^^ exposure, and slightly different levels by the eighth 
hour of Cd** exposure, but not significant difference (P > 
0.05). The Cd** cytotoxic responses were found to be 
essentially identical (Figure 4) and involved a 
disappearance of cytotoxic threshold and significantly 
reduced LCg^. 
It is yet to be determined whether GSH protects cells 
directly, by binding Cd**, or indirectly, perhaps by 
providing a source of cysteine to support MT synthesis or by 
mediating the Cd** induced synthesis of stress proteins 
(Shelton et al., 1986). The latter represents an early and 
rapid response that can be defined by gel electrophoresis of 
3 5 s methionine-labeled proteins. The former is a 
possibility that can be tested by modulating GSH levels in 
MT minus cells such as CHO to determine the effect of a 
reduced GSH level on Cd** cytotoxic response in the absence 
of MT synthesis. 
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ABSTRACT 
Relationships among cell growth, glutathione content 
and cadmium cytotoxicity were investigated in human lung 
carcinoma derived A549-T27 cells. Cellular glutathione 
content increased during the first 24 hours of culture, 
reaching a peak early in the logarithmic growth phase. 
Subsequently, glutathione content decreased throughout the 
remainder of the logarithmic growth phase, and decreased to 
its lowest level when the cells reached the plateau phase of 
growth. Cadmium cytotoxicity showed a change, which 
corresponded to that of cellular glutathione content when 
the cells were in the lag and logarithmic phases of growth, 
indicating that cadmium cytotoxicity is highly correlated 
with cellular glutathione content. A reproducible change in 
cellular glutathione content within each passage during 
three subcultures was also observed. 
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INTRODUCTION 
Glutathione (GSH) Is an ubiquitous Intracellular 
non-protein sulfhydryl compound whose concentration varies 
markedly among cells (Kosower and Kosower, 1978). Most 
cellular functions, especially cellular protective 
functions, of GSH are related to Its cellular concentration. 
The relative content of cellular GSH determines the 
cytotoxicities of many chemicals (Arrlck and Nathan, 1984; 
Crook et al., 1986; Hamilton et al., 1985; Kagedal et al., 
1986; Ketterer, 1982; Rolzln-Towel, 1985; Russo et al., 
1986), and of physical agents such as heat (Shrleve et al., 
1986; Freeman et al., 1985; Mitchell et al., 1983; Russo et 
al., 1985; Mitchell and Russo, 1983) and radiation (Durand, 
1984; Varnes et al., 1984; Biaglow et al., 1983; Vos et al., 
1984; Russo and Mitchell, 1984). 
Recent studies revealed that GSH plays an Important 
protective role in the early Cd^^ cytotoxic response (Kang 
and Enger, 1988; Slnghal et al., 1987). Depletion of 
cellular GSH by DL-buthlonine-SR-sulfoximine (BSO) or 
dlethylmaleate (DEM) sensitizes human lung carcinoma A549-
T27 cells to Cd cytotoxicity in a fashion that suggests 
that initial GSH content may be one of the critical factors 
which determine cellular resistance to Cd** (Kang and Enger, 
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1987). Cellular GSH content may change as a function of 
cell growth stage, that Is, as a function of time following 
subculture - during which time the cells progress from a lag 
phase to a period of exponential growth and, finally, to a 
plateau. GSH levels could also vary during the cell cycle. 
Such variation In GSH content would be expected to result In 
corresponding cell growth stage and/or cell cycle variation 
In Cd cytotoxic response. A number of studies have 
addressed the question of whether such growth related 
variations in GSH content occur. Studies on HE180, A431, 
KHT, CHO and HEp3 cells showed that cellular GSH content 
remains constant, but that drug (adrlamycln) cytotoxicity 
changes nonetheless as a function of the various phases of 
the cell cycle (Lee et al., 1988). Reduction of GSH levels 
with BSO was found to sensitize cells in Gl, S and G2-M 
phases to similar extents (Lee et al., 1988). 
Cellular GSH content was observed to change as a 
function of culture conditions (cell growth stage) in A549 
cells (Post et al., 1983). However, whether such variation 
in GSH content results in a concomitant variation in Cd** 
cytotoxicity as a function of cell growth stage has not been 
determined. In the case of variation in GSH content and/or 
Cd** cytotoxicity as a function of cell passage number, 
neither has been defined. Studies on such cell growth 
related variation in GSH content and/or Cd** cytotoxic 
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response are important in several contexts. First, they 
would help define the extent to which cell growth parameters 
are important in determining inter-experiment variations in 
cellular toxic response and to what extent changes in GSH 
levels are responsible for changes in Cd^^ cytotoxic 
response that occur during cell growth in culture. 
Second, experiments that have been performed to date to 
elucidate the relationships between GSH content and Cd** 
cytotoxic response have relied on comparison of different 
cell types, between which many other factors other than GSH 
levels may vary to effect differential Cd^"*" cytotoxicity; or 
on chemical modulation of GSH content, which may result in 
side effects of unknown magnitude and nature. A correlation 
of Cd** cytotoxic response with GSH levels as they vary 
"naturally" during cell growth would validate and better 
define the role of GSH in Cd** cytotoxic response. 
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MATERIALS AND METHODS 
Celle and cell çwltur? 
Human lung carcinoma derived A549-T27 cells were 
cultured as described (Kang and Enger, 1987). Stock 
cultures were passaged at 4 day intervals. All experiments 
were performed prior to the 20th passage. 
Cell growth determination 
Monolayer stock cultures in T75 flasks were washed with 
phosphate buffered saline (PBS), the cells were removed with 
trypsin-EDTA and re-established at 5 x 10® cells in 60 mm 
round cell culture dishes. The subcultures were harvested 
at 12 hour intervals for 120 hours and the cells obtained 
were counted with a Coulter counter. Cell growth rate was 
determined by plotting the log of cell number as a function 
of time. 
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Determination of acute Cd— çYtOtÇXiçity %n4 t9tal 9$H 
content 
Cells were seeded at 5 x 10^ cells in 35 mm dishes and 
exposed to various concentration of CdClg (0, 25, 50, 100 
uM) for 36 hours. Adherent cells were then harvested and 
counted with a Coulter counter. Total cellular GSH levels 
(including GSH and GSSG) were measured using the DTNB-GSSG 
reductase recycling assay (Tietze, 1969; Anderson, 1985). 
Briefly, the cells were trypsinized, rlnse.d with cold PBS, 
centrifuged at 4°C, resuspended in cold 0.6% sulfosalicylic 
acid, mixed vigorously ("vortexed"), and recentrifuged. The 
supernatant was then assayed for GSH content by measuring 
the change in color of DTNB at 412 nM in the presence of 
GSSG reductase (Sigma) and NADPH (Sigma). 
Statietical analyeie 
All data are presented as the mean of at least 
triplicate samples. Tests of significance were performed 
using the t-test. The Pearson product-moment correlation 
(r) was used to determine the relationship between GSH 
content and Cd** cytotoxicity in Figure 1 (Bruning and 
Kintz, 1987). 
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RESULTS 
Cellular GSH content in A549-T27 cells was observed to 
change dramatically as a function of cell growth stage. 
When A549-T27 cells were subcultured, cellular GSH content 
increased during the first 24 hours of culture, reaching a 
peak early during the logarithmic growth phase (Figure 1). 
Subsequently, GSH content decreased throughout the remainder 
of the log phase of growth, and decreased to the level that 
existed inially (at the time of subculture) when the cells 
reached the stationary, or plateau, phase of growth. 
Cd^"*" cytotoxicity, expressed as the number of adherent 
cells remaining in cultures exposed to 50 uM Cd** for 36 
hours relative to that in control cultures, changed in 
proportion to changes in cellular GSH content during the 
first 84 hours of culture (r = 0.82), a period of time 
corresponding to that which encompasses the lag and log 
phases of cell growth. After this time, when cell growth 
had reached stationary phase, Cd"*""*"- cytotoxicity no longer 
correlated with GSH content - cellular cytotoxic response 
decreased during plateau phase despite continued diminution 
in GSH content (Figure 1). Cells exposed to 25 uM or 100 uM 
Cd showed a similar pattern of response to that of the 
cells exposed to 50 uM Cd** (data not shown). 
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Cellular GSH content changed regularly and reproduclbly 
during three subcultures (Table 1). It Increased during 
the early stage of each of these passages and decreased at 
the end of egch passage. 
* 
I 
Figuer 1. Relations among cell growth, GSH content and 
Cd**-cytotoxicity in A549-T27 cells. Cell growth 
(#—#), GSH content ( | ) and Cd** 
cytotoxicity ( ^ ^ ). Data are presented as 
means + SDs from triplicate samples within each 
passage 
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Table 1. Changés in cellular glutathione content as a 
function of cell culture passage 
Passage! GSH (nmoles/lO® cells)® Cell number (count x 10®)^ 
Number 20 hour 96 hour 96 hour 
18 19.2 ± 1.3 12.4 
19 18.6 ± 0.6 11.2 
20 17.3 ± 2.1 11.8 
± 0.6 7.12 ± 0.29 
±2.0 6.65 ±  1.63 
± 1.5 7.41 ± 1.24 
*Total cellular GSH content of cells grown in a T-75 
flask. Data are presented as means + SDs. 
^Total cell number in each T75 flask was determined at 
the end of 96 hours in culture. Data are means ± SDs. 
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DISCUSSION 
Lee et al. (1988) found that cellular GSH content in 
different phases (61, S, G2-M) of the cell cycle of rodent 
and human tumor cells increased in proportion to increases 
in cell volume, indicating that cellular GSH content is not 
cell cycle dependent. However, the results reported here 
and those of Post et al. (1983) demonstrated a pronounced 
variation in GSH content as a function of cell growth stage. 
In both studies, GSH content was found to increase during 
lag phase, peak early in log phase, and decrease as cells 
progressed to plateau phase. An important aspect of these 
results is the fact that GSH content not only differs among 
lag, log and plateau phases, but also changes markedly 
within the logarithmic growth phase. 
Cd** cytotoxicity was in this study found to correspond 
to cellular GSH levels throughout the log growth phase. 
This observation confirms the relationship between cellular 
GSH content and Cd cytotoxic response observed in cells 
whose GSH levels were reduced with BSO or DEM (Kang and 
Enger, 1987). 
Because of the importance of GSH content to cellular 
cytotoxic responses in general, the observation of 
pronounced variation in GSH content throughout the growth 
phases that follow subculture means that care must be taken 
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to ensure in all cellular toxicology experiments that all 
cell growth parameters are,standardized and monitored. 
When A549-T27 cells reached the stationary groWth 
phase, Cd** cytotoxicity no longer corresponded to relative 
cellular GSH content. This phenomenon may relate to and 
derive from the multifactorial nature of cellular regulation 
of Cd** cytotoxicity. Numerous studies have shown that Cd** 
accumulation is one of the important determinants of the 
overall cytotoxicity of this heavy metal (Bracken et al., 
1984; Enger et al., 1981; Hinkle et al., 1987, Enger et al., 
1986). Cells at stationary phase accumulate less Cd** than 
cells in logarithmic growth (Fischer, 1985). This may thus 
be one of the important factors which desensitize the 
stationary phase cells to Cd^^ cytotoxic effects. 
Because of the heterogeneous nature of most available 
human tumor derived cell lines (Enger et al., 1986), change 
in culture phenotype as a function of passage could occur 
readily as a consequence of differential growth rates of 
subpopulations. This source of variation may be controlled, 
as in these studies, by using a cloned subpopulation 
(A549-T27). A number of studies have, however, shown marked 
changes in phenotypic properties such as tumorigenicity and 
metastatic potential in such cloned subpopulations. In some 
instances these changes have been attributed to changes in 
gene expression due to altered patterns or amounts of DNA 
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methylatlon (Frost and Kerbel, 1983). This and other 
factors, which produce inherently greater rates of genetic 
and epigenetic change in tumor cells, could lead also to 
changes in GSH content and/or metabolism as a function of 
passage in A549-T27 cells. The studies reported here showed 
that the pattern of GSH content variation seen during one 
passage occurs during several, but do not determine whether 
GSH content and/or patterns of variation during subculture 
growth maintain or alter during an extended number of 
passages. That such alteration as a function of passage may 
occur is indicated by the differences in GSH content 
observed in the experiments reported here on the effects of 
cell growth stage and those dealing with the reproducibility 
of the pattern during passage. In both sets of experiments, 
GSH was measured 20 hours following subculture. However, a 
value of about 30 nmol/10^ cells was obtained in one study 
(growth stage), - 20 nmol/10^ cells in the other. The cells 
were in one instance cultured in T flasks and in the other, 
round dishes. In addition, cells were used at passage 15 
for the growth phase studies and at passages 18-20 for those 
examining the reproducibility of the pattern of GSH 
variation during subculture growth. These results suggest 
that future studies should necessarily examine also the 
extent, nature and mechanisms of GSH variation as a 
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function of passage number and exact cell culture 
conditions. 
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ABSTRACT 
Glutathione (6SH) depletion sensitizes human lung 
carcinoma (A549-T27) cells to the cytotoxic effects of Cd**. 
The effects of GSH depletion on Cd"*"^ accumulation and Cd*^ 
induced metallothionein (MT) accumulation were investigated 
to determine the possible role of these Cd** responses in 
the sensitization process. Cellular GSH was depleted to 
about 20% or 25% of control levels with buthionine 
sulfoximine (BSO) or diethylmaleate (DEM), respectively. 
Neither treatment significantly affected Cd** accumulation. 
However, BSO treatment increased Cd^"*"-induced MT 
accumulation in a dose-dependent fashion and DEM decreased 
Cd***^-induced MT accumulation. The results indicate that 
neither enhanced Cd** accumulation nor reduced MT synthesis 
plays a primary role in effecting increased Cd"*"* 
cytotoxicity in A549 cells with reduced GSH levels. This 
work also suggests that intracellular cysteine levels may 
limit Cd^^-induced MT accumulation and that the differential 
effects of BSO and DEM on Cd** induced MT accumulation may 
contribute to the enhanced Cd** cytotoxic response that 
occurs in cells whose reduced GSH levels are comparable but 
which were induced with DEM instead of BSO. 
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INTRODUCTION 
Glutathione (GSH), an ubiquitous tripeptide and the 
most important intracellular nonprotein thiol, plays an 
important role in intermediary metabolism and molecular 
transport as well as in the maintenance of enzyme activity 
and membrane integrity in cells exposed to toxicants and 
active oxygen (Meister and Anderson, 1983; Kosower and 
Kosower, 1978; Hamilton et al., 1985; Arrick et al., 1982; 
Biaglow et al., 1983; Crook et al., 1986). 
Studies on A549 human lung carcinoma cells, which are 
relatively Cd** resistant and have an exceptionally high 
level of GSH, showed that GSH depletion by either diethyl 
maleate (DEM) or buthionine sulfoxinine (BSO) sensitizes 
them to Cd** (Kang and Enger, 1987). However, the role of 
GSH in Cd** detoxification is not fully defined. Although 
the affinity of Cd** for GSH makes direct detoxification by 
binding an attractive mechanism for GSH modulation of 
cellular Cd** response (Perrin and Watt, 1971; Vallee and 
Ulmer, 1972; Jacobson and Turner, 1980; Christie and Costa, 
1984; Dudley and Klaassen, 1984), indirect mechanisms 
involving GSH cannot be excluded. 
Cellular GSH status can affect the synthesis of 
macromolecules (Kosower and Kosower, 1978). The effect of 
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6SH on the synthesis of thiol-rich proteins, such as 
metallothioneins (NTs), is of particular interest in the 
context of the Cd** cytotoxic response. Seagrave et al. 
(1983) treated Cd**-resistant variants of CHO cells with 
subtoxic Cd concentrations, and found that several 
variants subsequently showed a 40% decrease in cellular 6SH, 
the time course of which corresponded roughly with the time 
of maximal MT synthesis. An inverse relationship between 
levels of MTs and GSH after Cd** treatment was also observed 
in vivo by Wong and Klaassen (1981), who suggested that due 
to the dramatic increases in MT synthesis induced by Cd**, 
there is a temporary depletion of cellular cysteine pools, 
which in turn limits the biosynthesis of GSH and leads to a 
temporary reduction in GSH concentration. However, there is 
no direct evidence linking cellular GSH levels and HT 
synthesis. 
Cd uptake and intracellular accumulation are one of 
the important determinants of the overall cytotoxicity of 
this heavy metal. Studies on bovine kidney cells showed a 
high correlation (r = 0.93) of the degree of cytotoxicity 
with cellular Cd** burden and suggested a cumulative 
mechanism of toxicity (Bracken et al., 1984). In some 
instances, Cd** sensitive cells have higher Cd** uptake 
rates. Monocytic human leukemia cells, for example, are 
usually more Cd** sensitive and take up Cd** at a faster 
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rate than normal mononuclear blood cells (Enger et al., 
1984). Also, relatively high Cd** sensitivity in AlOlD 
human melanoma cells and variation in response among its 
subpopulations are due to enhanced and differential Cd** 
uptake, respectively (Enger et al., 1986). 
Because the structural and biochemical integrity of the 
cell membrane depends upon an appropriate cellular GSH 
status (Kosower and Kosower, 1978), it is possible that 
changes in cellular GSH levels affect cellular Cd** uptake 
and accumulation. 
In the present work, the effects of cellular GSH 
depletion by BSO or DEM on MT and Cd** accumulation in A549 
cells were investigated to better define the role of GSH in 
Cd** cytoprotection. 
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MATERIALS AND METHODS 
Chemicals 
CdClg and dimethyl sulfoxide (DMSO) were obtained from 
Fisher Scientific Company (Fairlawn, NJ), 
DL-buthionine-[S,R]-sulfoximine (BSO), dithiothreitol (DTT) 
Nonidet P-40 (NP-40) and iodoacetic acid from Sigma Chemical 
Co. (St. Louis, MO), and diethyl maleate (DEM) was from 
Aldrich Chemical Company Inc. (Milwaukee, WI). 
2-Mercaptoethanol and other SDS-page gel electrophoretic 
reagents and equipment were obtained from Bio-Rad 
Laboratories (Richmond, CA) ^^^CdClg and ^®S-cysteine are 
the products of New England Nuclear Corporation (Boston, 
MA), and of Amersham (Arlington Heights, IL), respectively. 
McCoy's 5A medium was obtained from GIBCO (Grand Island, 
NY). Fetal calf serum was purchased from HyClone (Logan, 
UT). 
Cells and cell culturlna conditions 
Human lung carcinoma A549-T27 cells were obtained from 
Dr. Harold Moses at the Mayo Clinic and Foundation. Cell 
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culture conditions were described in detail earlier (Kang 
and Enger, 1987). 
Protocols for GSH modulation and determination of Cd— 
accumulation 
Cells were exposed to either 10 mM BSO for 8 hours 
beginning 16 hours after subculture by direct addition of 
the agent dissolved in phosphate buffered saline (PBS) or 
0.5 mM DEM for 4 hours beginning 20 hours after subculture 
by addition of the agent dissolved in DMSO diluted with 
Hank's balanced salt solution (HESS). The BSO or DEM 
treated cells were then washed with PBS and exposed to 
^^^CdClg in fresh media for determination of Cd** 
accumulation. 
Both drug treated and untreated control cells were 
1 QO 
exposed to 1 uCi/ml CdClg at a concentration of 5 UM 
CdClg for a designated time course beginning 24 hours 
following subculture, or to various concentrations of CdClg 
for 8 hours. The cells were then trypsinized, washed with 
PBS and counted with a Coulter counter. ^®^cd accumulation 
in the cells was determined by lysing cells with NP-40 and 
counting aliguots in a liquid scintillation spectrometer. 
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Determination of MT levels 
The relative amounts of MT accumulated in response to 
Cd** with different treatments was determined by measuring 
3 5 
the amount of [ S] incorporated into MT during 12 hours 
3 5 
exposure to S cysteine (Enger et al., 1979). The 
procedure is briefly as follows: monolayers are harvested 
with trypsin-EOTA, washed with cold PBS, suspended and lysed 
in O.OIM NaCl, O.OIM Tris-HCl pH 7.2 at 20°C, 1.5 mM MgCl, 
0.2 mM DTT containing 1% (v/v) Nonidet P-40. Nuclei are 
removed by centrifugation, the cytosolic fractions are 
diluted 1:4 with Laemmli sample buffer (Laemmli, 1970) 
containing 10% 2-mercaptoethanol, denatured by boiling 5 
min., made O.IM with iodoacetic acid in 1.5 M Tris-HCl pH 8 
at 20°C, then incubated at 50°C in the dark for 45 min. 
prior to discontinuous (4.5-15%) polyacrylamide 
gel-electrophoresis of aliguots containing equal 
radioactivity or equal cell numbers. The differences in MT 
accumulation among treatments were analyzed by densitometric 
scanning of fluorographs. 
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Statiptjçal aseav 
Data were initially analyzed by one-way ANOVA. 
Comparisons between controls and each treatment at each time 
point and concentration were analyzed by student's t test. 
The Pearson product-moment correlation (Bruning and Kintz, 
1987) was used to determine the relationship between BSO 
concentration and MT accumulation (Figure 4). Differences 
were considered to be significant when p < 0.05. 
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RESULTS 
The effects of BSO or DEM treatment on 
Cd**-accumulation in the A549-T27 cells were investigated 
both as a function of time and as a function of Cd** 
concentrations. As shown in Figure 1, Cd'*"'' accumulated 
linearly with time when A549-T27 cells, subcultured for 24 
hours, were exposed to 5 uM CdClg for 10 hours. There were 
no significant effects of BSO or DEM treatment on the Cd** 
accumulation when the cells were subcultured for 16 hours 
and subsequently exposed to 10 mM BSO for 8 hours, or 
subcultured for 20 hours and subsequently exposed to 0.5 mM 
DEM for 4 hours, respectively, before exposure to 5 uM CdClg 
(•fable 1). 
Cells subcultured for 24 hours and exposed to different 
concentrations of CdClg for 8 hours showed non-linear 
concentration dependence for Cd** accumulation (Figure 2). 
Below 2.5 uM Cd**, accumulation increased rapidly with dose. 
Above this value Cd** accumulation increased much less 
rapidly as a function of dose. Although DEM treatment 
decreased Cd** accumulation at a low concentration of CdClg 
(2.5 uM), there were no significant effects of either BSO or 
DEM treatments on Cd^^ accumulations at higher 
concentrations of CdClg (Table 2). 
Figure 1. Cd"*"*" accumulation by A549-T27 cells as a function 
of time in cells exposed to 5 uM Cd^^. The best 
fit straight line is established using a linear 
regression model (Steel and Torrie, 1980). Data 
are presented as mean values + SDs 
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Table 1. Effects of BSO and DEM on kinetics of Cd^^ uptake 
by A549-T27 cells 
Time (Min.) Cd"*"^ uptake (% of Control) 
BSO* (10 mM) DEM* (0, .5 mM) 
15 96.5 ± .3" 104.5 ± 3.2 
30 102.3 ± 3.2 96.5 ± 3.6 
60 105.6 ± 4.1 104.1 ± 1.0 
120 88.3 ± 6.0 105.3 ± 7.4 
240 103.6 ± 1.0 103.1 ± 3.3 
360 87.2 ± 9.6 97.5 ± 2.0 
480 109.2 ± 6.0 95.9 + 3.4 
*A11 vehicle controls are negative. 
^Data are Means ± SDs. 
FM! 
Figure 2. accumulated by A549-T27 cells in eight hours 
as a function of Cd^^ concentrations. The best 
fit curve is established using a nonlinear 
regression model (Motulsky and Ransnas, 1987). 
Data are means + SDs 
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Table 2. Effects of BSO and DEM on concentration dependent 
Cd** uptake by A549-T27 cells 
[Cd"*"*"] Cd"*"*" uptake (% of control) 
(UM) BSO® (10 mM) DEM® (0.5 mM) 
2.5 90.8 ± 9.5^ 88.5 ± 3.3* 
5.0 100.2 ± 5.2 96.3 ± 4.9 
10.0 99.6 ± 8.5 102.5 ± 6.1 
20.0 106.6 ± 2.9 106.6 + 6.6 
®A11 vehicle controls are negative. 
^Data are means + SDs. 
* p < 0.05. 
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Effects of BSO or DEM treatment on Cd**-induced NT 
levels are shown in Figure 3. 10 uH treatment induced 
significant MT accumulation during 12 hours Cd** exposure. 
BSO and DEM treatments differentially affected the 
+4" Cd -induced HT accumulation. BSO significantly increased 
the Cd**-induced MT accumulation as indicated in both Figure 
3 and Table 3. Furthermore, the BSO effect on MT 
accumulation is dose-dependent. As shown in Figure 4, MT 
accumulation highly correlates with BSO concentration (r = 
0.82), i.e. a higher concentration of BSO causes a greater 
accumulation of MT. DEM, on the other hand, decreased the 
MT accumulation. There is no significant effect of DMSO, 
which is a vehicle for DEM, on Cd**-induced MT accumulation 
(Figure 3 and Table 3). 
Figure 3. Effects of BSO and DEM on Cd**-induced MT 
accumulation. Sample preparation is as described 
in Materials and Methods. Treatments are as 
labelled. Equal amounts of radioactivity were 
applied and electrophoresed 
r7~* 
F 
t ' '» f SSSSSll' 9cd & DMSO 
: : f 
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Table 3. Relative ^^S-cysteine incorporation into NT and 
into a 14.4 kD reference protein in differently 
treated A549-T27 cells 
14.4 kD MT MT/14.4 
Control 23.6 ± 1.3* 5.6 ± 1.0 0.24 
Cadmium 18.9 ± 0.4 36.5 ± 1.2 1.90* 
DMSO + Cadmium 12.0 ± 0.2 26.9 ± 1.7 2.20* 
BSO + Cadmium 16.1 ± 1.3 59.0 ± 3.8 3.90** 
DEM & DMSO + Cadmium 10.0 ± 1.0 12.8 ± 0.6 1.28** 
*Data presented as means + SDs. 
significant difference front control. 
**Significant difference from Cd**-treatment only. 
Figure 4. Effects of different BSO concentrations on 
Cd**-induced MT accumulation. Samples were 
adjusted to equal cell density and loaded in 
equal volume for SDS gel-electrophoresis. Data 
are presented as the ratios of BSO treated to 
control (BSO untreated) values 
MT Content (Ratio; BSO Treated vs. Untreated) 
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DISCUSSION 
As reported previously (Kang and Enger, 1987), 
treatment of A549-T27 cells with 10 mM BSO for 8 hours or 
0.5 mM DEM for 4 hours depleted their cellular GSH levels to 
15-25% of control. The depletion of cellular GSH sensitizes 
the A549-T27 cells to Cd** to the extent that the normal 
cytotoxic threshold of 5 uM CdClg is eliminated and the LCgg 
for Cd^^ is reduced from 31 uM CdClg to 21 uH or 15 uM by 
BSO or DEM treatment respectively. 
Although there is a significant decrease in the GSH 
levels of the DEM and BSO treated A549-T27 cells, they are 
still higher than that of normal fibroblasts and similar to 
that of untreated human tumor cells (Enger et al., 1984). 
If there exists in all cells a basic cellular level of GSH 
which is required to maintain the biochemical integrity and 
biological functions of the cell membrane, such a level 
should still exist in the DEM and BSO sensitized A549-T27 
cells. On this basis, their membrane integrity should be 
unaffected and Cd** accumulation should not be enhanced 
because of membrane damage. Such an hypotheses is in accord 
with the results of this study, which showed no significant 
effect on Cd^^ accumulation of 75- 85% GSH depletion in 
A549-T27 cells. The results of the Cd** accumulation 
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studies show definitively that Cd^^ sensitization in 
A549-T27 cells with reduced GSH content is not due to 
alterations in Cd^* uptake. 
BSO inhibits selectively the activity of 
y-glutamylcysteine synthetase to block the GSH synthetic 
pathway. DEM, on the other hand, conjugates with GSH to 
deplete cellular GSH content. Thus, both reagents decrease 
cellular GSH, but in ways that potentially have opposite 
effects on cellular cysteine content. The effects of BSO or 
DEM on cellular GSH and cysteine contents, and the possible 
subsequent effects on MT synthesis are presented in the 
following model: 
BSO DEM 
Cysteine —;w}»^Y"-Glutamylcysteine —y-*GSH îîî^^DEM-SG 
I f t 
I Glutamate Glycine 
MT 
The model predicts that BSO, by decreasing GSH 
synthesis, spares intracellular cysteine and thus 
potentially enhances MT synthesis; whereas DEM, by 
conjugating with and depleting cellular GSH, spends 
intracellular cysteine and potentially decreases MT 
synthesis (in the event that cysteine content is rate 
limiting). The results obtained with A549-T27 cells accord 
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with the model. As shown in Figures 3 and 4, BSO treatment 
indeed increased Cd**-induced MT accumulation in a BSO-dose 
dependent fashion. DEM treatment, as predicted, decreased 
Cd"*"^ induced MT accumulation (Figure 3). 
Although BSO treatment enhances Cd**"^-induced MT 
synthesis, it still sensitizes the cells to Cd** (Kang and 
Enger, 1987). This indicates that reduced GSH levels do not 
sensitize cells to Cd** by altering an MT response 
mechanism. It also suggests that intracellular cysteine 
levels may limit Cd^^ Induced MT synthesis rates, an 
hypothesis which will be tested in a future study. 
Another suggestion from this study is that the 
differential effects of BSO and DEM on Cd** induced MT 
accumulation may partially account for the difference in 
Cd"*"*" cytotoxicity between BSO and DEM treated cells with 
comparable residual GSH levels. 
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ABSTRACT 
Subpopulations T20 and T27, cloned from the human lung 
carcinoma line A549, were screened for variation in cadmium 
cytotoxic responses. Cell survival, Cd accumulation, 
metallothionein (MT) content, glutathione (GSH) content and 
its changes were studied to define their roles in cadmium 
damage and cytoprotective responses in the two 
subpopulations. 
Significant differences in Cd^^ cytotoxicity were 
observed. T27 has an LCgg of 31 uM Cd"*"^ and a cytotoxic 
response threshold of 5 uM Cd**, whereas the T20 LCg^ is 15 
uM Cd** and there is no observed threshold for cytotoxicity. 
That this difference in Cd** cytotoxic response is not due 
to a difference in the capacities of T20 and T27 for MT 
synthesis was indicated by comparable MT accumulation 
responses to 10 uM Cd**. A difference in Cd** accumulation 
also cannot account for the difference in the cytotoxic 
response. Studies of cellular Cd** accumulation as a 
function of time exposed to 5 uM Cd** and as a function of 
Cd** concentration show that T27, which is more Cd** 
resistant, actually accumulates more Cd** than does T20. 
The two subpopulations have comparable initial GSH contents, 
but they differentially change when the cells are Cd** 
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stimulated. 
The results show that the variation in Cd"*"*" cytotoxic 
response between two subpopulations of A549 cells is not 
attributable to alterations in MT response nor to a 
difference in their initial 6SH content (we have shown that 
depletion of cellular GSH content sensitizes A549-T27 cells 
to Cd**). Cd** cytotoxicity is also not correlated with 
Cd*^ accumulation. The fact that T27 accumulates more Cd*^ 
and yet is more Cd** resistant than T20 suggests that T27 
has a much more effective non-MT mechanism to handle 
intracellular Cd"*"*". This may involve GSH metabolism or yet 
undefined molecular factors. 
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INTRODUCTION 
The human lung carcinoma-derived cell line A549 is 
markedly Cd** resistant relative to early passage normal 
human fibroblasts and most other human tumor cell lines 
(Enger et al., 1986a). Several mechanisms are known to 
confer such enhanced Cd**-detoxification both in vivo and in 
vitro. Increased metallothionein (MT) induction capacity 
++ 
enhances cellular Cd resistance (Hildebrand et al., 1979). 
The synthesis of MT is stimulated by administration of Cd'*'^. 
The induced MTs bind to Cd** and reduce its cytotoxicity 
(Webb, 1979; Enger et al., 1986b). Cellular Cd** resistance 
is also modulated by differences in Cd** uptake, i.e. 
decreasing cellular Cd** uptake will increase cellular Cd** 
resistance. Variation in Cd** resistance among human 
leukemic cells is due primarily to altered Cd** uptake 
(Enger et al., 1984). Also, monocytic leukemia cells are 
usually more Cd** sensitive and take up Cd** at a faster 
rate than normal mononuclear cells. Relatively high Cd** 
sensitivity in the human melanoma cell line AlOlD and 
variation in response among its subpopulations are also due 
to enhanced and differential Cd** uptake, respectively 
(Enger et al., 1986a). 
Several authors have reported that A549 cells have a 
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much higher level of cellular glutathione (GSH) than that of 
normal and most other tumor cells (Brodie and Reed, 1985; 
Russo et al. 1986; Enger et al., 1986a). GSH plays an 
important role in maintaining cellular redox status (Kosower 
and Kosower, 1978), and in protecting cells from 
environmental stresses, such as ionizing radiation, heat, 
and toxic chemicals (Biaglow et al., 1983; Mitchell and 
Russo, 1983; Freeman et al., 1985; Ketterer, 1982). It is 
possible that the relatively high GSH level observed in the 
A549 cells is one of the factors responsible for their high 
Cd** resistance. 
Studies In vivo have shown that the concentration of 
GSH in the liver and kidney of rats can be decreased by Cd^^ 
(Wong and Klaassen, 1981) and lowered GSH levels sensitize 
animals to Cd -induced liver damage (Dudley and Klaassen, 
1984). Recently, we found that depletion of GSH levels by 
exposing A549 cells to diethyl maleate (DEM) or buthionine 
sulfoximine (BSO) sensitized them to Cd** (Kang and Enger, 
1987). 
Seagrave et al. (1983) treated different Cd**-resistant 
variants of Chinese hamster ovary (CHO) cells with maximal 
subtoxic levels of CdClg and observed that the kinetics of 
Cd**-induced changes in cellular GSH levels differ among the 
variants. A variant that is more resistant to cd** than 
predicted on the basis of its MT synthesis response did not 
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show the initial Cd^"*"-induced reduction of GSH content that 
was shown by the other variants. Their results suggested 
that differential kinetics of Cd'^^-induced changes in GSH 
levels may, along with cadmium-induced MT synthesis, play a 
role in modulating Cd cytotoxic response. 
Clonal subpopulations of the A549 line vary 
significantly in Cd^* cytotoxic response (Enger et al., 
1986a). The purpose of the present study was to determine 
which of the above factors (or others not yet defined) are 
the determinants of the clonal variation of cadmium 
cytotoxic responses in subpopulations of the A549 line. 
Because T20 and T27 differ from each other to the greatest 
extent of the subpopulations cloned from A549, these were 
chosen for comparison. 
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MATERIALS AND METHODS 
Cells and cell culturina conditions 
Subpopulations (T20 and T27) of human lung carcinoma 
derived A549 cells, obtained from Dr. Harold Moses at the 
Mayo Clinic and Foundation, were routinely grown in McCoy's 
5A medium supplemented with 10% fetal calf serum (Hy Clone), 
2.2 g/1 of sodium bicarbonate, and antibiotics at 37°C and 
pH 7.0- 7.2 in a humidified atmosphere of 95% air, 5% COg. 
Stock cultures were passaged at 4 day intervals. Clones 
were established and DNA contents were determined by J. G. 
Tesmer of the Life Sciences Division, Los Alamos National 
Lab. The parent population has a flow cytometric DNA 
histogram reflective of at least two subpopulations 
differing in DNA content by about 16%. Each clone tested 
showed a DNA histogram indicative of a pure population in 
terms of DNA content. This was determined as described 
previously (Enger et al., 1986a). Tests for mycoplasma were 
negative. Cells were removed from stock cultures with 
trypsin-EDTA, counted with a Coulter counter and plated in 
25-cmf tissue culture flasks at 5 x 10® cells/flask 16 hr 
prior to each experiment. 
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cytotoxic response 
400-500 cells were plated in 6 ml of medium in 60-mm 
Petri dishes in the presence of 5, 10, 20, 30, or 40 uH 
CdClg and incubated 10 days for macroscopic colony 
formation. The plates were then rinsed with 
phosphate-buffered saline (PBS) and stained with crystal 
violet. The numbers of colonies formed were enumerated as a 
function of Cd concentration. 
Gellylar accumulation 
1 OQ 
Cells were exposed to 1 uCi/ml CdClg at a 
concentration of 5 uM Cd** for a designated time course, or 
to various concentrations of Cd** for 8 hours. The cells 
were then trypsinized, washed with PBS and counted with a 
1 AQ 
Coulter counter. Cd accumulated in the cells was then 
determined by lysing cells with non-ionic detergent and 
counting aliguots in a liquid scintillation spectrometer 
(Hildebrand et al., 1979). 
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Metallothloneln accumulation 
The relative amount of MT accumulated In response to 
Cd** was determined by measuring the amount of [^®S] 
Incorporated Into metallothloneln during 12 h exposure to 
cysteine (Enger et al., 1979). Labeled cells were 
harvested with trypsln-EDTA (Glbco), washed with cold PBS, 
suspended and lysed In O.OIM NaCl, O.OIM Trls-HCl (Blo-Rad) 
pH 7.2 6 20°C, 1.5 mM MgCl, 0.2 mM DTT (Sigma). Nuclei were 
removed by centrlfugatlon, the cytosollc fractions were 
diluted 1:4 with Laemmll sample buffer (Laemmll, 1970) 
containing 10% 2-mercaptoethanol (Blo-Rad), denatured by 
boiling 5 mln., made O.IM with lodoacetlc acid (Sigma) In 
1.5 M Trls-HCl pH 8 § 20®C, then Incubated at 50°c In the 
dark for 45 mln. prior to discontinuous (4.5-15%) 
polyacrylamlde electrophoresis of allquots containing equal 
radioactivity. MT was resolved electrophoretlcally and Its 
content of Incorporated S compared with that of a protein 
of 14.4 KD. 
GSH assav 
GSH levels In treated and untreated cells of each 
subline were measured by the DTNB-GSSG reductase recycling 
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assay (Tietze, 1969 and Anderson, 1985). The cells were 
trypsinized, rinsed with cold PBS, centrifuged at 4°C, 
resuspended in cold 5% sulfosalicylic acid, vortexed, and 
recentrifuged. The supernatant was then assayed for GSH and 
6SS6 content by measuring the change in color of DTNB at 412 
nm in the presence of GSH reductase and NADPH (Sigma). 
GSH kinetics 
For the study of GSH content changes caused by Cd** 
stimulation, 0.5 x 10^ cells in 6 ml medium were seeded in 
60 mm dishes and Incubated at 37°C for 16 hrs prior to 
adding 5 uM Cd** to each dish. The changes in GSH content 
of each subclone were measured as a function of incubation 
time with Cd^^, and as a function of Cd** concentration. 
Statistical analysis 
Data were initially analyzed by one-way analysis of 
variance. Comparisons between controls and treatments and 
between two treatment groups at each time point were 
analyzed by Student's t test. For the statistical analysis 
of the data from Cd** cytotoxic response experiments, the 
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slope ratio assay was used. Differences were considered to 
be significant when P < 0.05. The data in Figure 2A were 
analyzed by parallel lane assay (Finney, 1978). 
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RESULTS 
Subpopulations and Tjy of A549 differ significantly 
in Cd** cytotoxic response. As indicated in Figure 1, the 
concentration of Cd^^ required to inhibit colony formation 
by 50% (the LCgQ value) differs greatly between these 
subpopulations. T27 cells, representing a more 
Cd**-resistant subline, have an LCgg value of 31.0 uM, and 
T20 cells, a more Cd^^ sensitive subline, have an LCg^ value 
of 15.0 uM. In addition, T27 cells have a cytotoxic 
4.4. 
response threshold of 5 UM Cd and T20 cells have none. 
These differences are very significant (P < 0.05). 
To determine whether altered Cd*^ accumulation 
contributes to the difference in Cd** cytotoxic response, 
1 AO 
T20 and T27 cells were exposed to 5 uM CdClg and the time 
course of Cd accumulation was determined for each. The 
two sublines were also exposed to varying concentrations of 
Cd** for 8 hours to determine the concentration dependence 
of Cd** accumulation. As shown in Figure 2, panel A and B, 
there is a significant difference in the rate at which T20 
J.J. 
and T27 accumulate Cd under these conditions (P < 0.05). 
However, it is T27 (the more resistant cell) that takes up 
more Cd**, both at different times of exposure to 5 uM Cd** 
(panel A) and when exposed to differing Cd** concentrations 
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for 8 hours (panel B). 
GSH content in the A549 cells varies dramatically as a 
function of cell growth stage (Post et al., 1983) and to an 
as yet undetermined extent as a function of cell culture 
passage. Therefore, the GSH content of the T20 and T27 
cells was measured at the same passage and the same cell 
growth stage (time since subculture). As shown in Figure 3, 
the GSH contents of T20 and T27 cells at passage 19 and 
subcultured for 16-20 hours are not significantly different 
(P > 0.05). When exposed to 5 UM Cd^^, the T27 cells did 
not show a significant difference in the GSH content as a 
function of time in treated and untreated cells (panel A of 
Figure 3, P > 0.05). The T20 cells showed a significant 
difference in the GSH content of Cd** treated and untreated 
cells 2 and 4 hours after Cd** exposure (panel B of Figure 
3, P < 0.05). When the GSH levels in the treated cells are 
presented as percent of control, a significant difference in 
the GSH content of two and four hour Cd** exposed T20 and 
T27 cells is apparent (panel A of Figure 4, P < 0.05). T20 
cells have a significant initial decrease in GSH content not 
seen in T27. There are also significant differences in GSH 
content changes between the two subpopulations when they are 
exposed to different concentrations of Cd^^ for 8 hours 
(panel B of Figure 4, P < 0.05). 
Relative MT accumulation in T20 and T27 in response to 
Figure 1. Cd"*"^ cytotoxic response in T20 and T27 
subpopulations of A549. The cells were exposed 
to different concentrations of CdClg at a cell 
density of 400-500 cells/dish during a 10 day 
incubation. Each point is expressed as 
mean ± SD. LCg^ values were calculated by the 
Trimmed Spearman-Karber method (Hamilton et al., 
1977). T27 cells ( # ) have an LCg^ of 31.0 
uM Cd** and a response threshold of 5 uH Cd**. 
T20 cells ( A—A ) have an LCgg of 21.0 uM and 
no observed threshold 
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0.10 
Cadmium Concentration (uM) 
Figure 2. Cd** uptake and accumulation in A549 T20 and T27 
cells. Panel A shows Cd** uptake and 
accumulation in T27 ( # # ) and T20 ( A—A ) 
cells as a function of the time cells were 
exposed to 5 uM CdClg. The best fit straight 
lines are established using a linear regression 
model (Steel and Torrie, 1980). Panel B shows 
Cd** uptake and accumulation in T20 ( A A ) 
and T27 ( # # ) cells as a function of the 
Cd** concentration to which the cells were 
exposed for eight hours. The best fit curves are 
established using a nonlinear regression model 
(Motulsky and Ransnas, 1987). There is a 
significant difference in Cd^^ uptake and 
accumulation between the two subpopulations 
(P < 0.05). It is the T27 subline which takes up 
and accumulates much more Cd*^ in the two 
protocols 
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Figure 3. GSH kinetic changes in A549 T20 and T27 cells 
exposed to 5 uH Cd^^. Panel A, GSH content 
changes in T27 cells treated with 5 uM Cd^^ 
( ^ ) and control ( O—O ) • GSH content 
increases as a function of time both in treated 
and control cells. There is no significant 
difference in GSH kinetic changes between the 
treated and control cells (P < 0.05). Panel B. 
T20 cells treated with 5 uM Cd^^ ( A—A ) and 
control ( ). GSH content increases in 
control cells and decreases in the Cd^^ treated 
cells in the first 4 hours. This difference is 
very significant (P < 0.05) 
8 10 0 2 
Incubation Time (Hours) 
' T 
* 
Figure 4. GSH kinetic changes, expressed as percent of 
control, in cells treated with Cd^^. Panel A, 
GSH content in T20 ( ék A ) and T27 ( % % ) 
as a function of time exposed to 5 uM Cd^^. GSH 
content in T27 cells did not show any significant 
Cd**-induced change, but that of T20 cells showed 
a significant decrease in the first 4 hours of 
Cd^^ exposure. The difference in GSH kinetic 
changes between the two in the first 4 hours is 
very significant (P < 0.05). Panel B. T20 and 
T27 cells were exposed to varying concentrations 
of Cd^^ for 8 hours. GSH contents in T20 cells 
( A—• ) showed a greater [Cd^^] dependent 
decrease than did T27 ( # # ) cells (P < 0.05). 
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+4* 3 5 Cd was compared by measuring the amounts of S cysteine 
incorporated into MT during a twelve-hour period following 
exposure to 10 uM Cd**. As seen in Figure 5, T20 and T27 
accumulate comparable amounts of MT when exposed to this 
concentration of Cd** for the designated time period. 
Quantitation (by densitometric scans of gel exposed 
35 fluorographs) of the amount of S cysteine incorporated 
into MT relative to that incorporated into a reference (14.4 
KD) protein showed there to be no difference in relative 
cadmium-induced MT accumulation in T20 and T27. These data 
are shown in Table 1. 
Figure 5. Incorporation of S cysteine Into 
electrophoretlcally resolved HT and other 
proteins in control and Cd^^ treated T20 and T27 
cells. Lanes 1 and 2, control and 10 uM 
Cd**-treated T20 cells; and lanes 3 and 4, 
control and 10 uH Cd**-treated T27 cells, 
respectively. 
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97.4 
66.2 
21.5 
14.4 
MT 
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Table 1. Relative cysteine incorporation into MT and 
into a 14.4 KD protein in control and Cd-induced 
A549 subpopulations T20 and T27 
T20 T27 
Control Cd^^ Control Cd"*"^ 
MT band 
14.4 kd band 
MT/14.4 
4.00 
16.30 
0.25 
34.40 
6.90 
4.98 
5.00 
16.60 
0.30 
28.70 
5.60 
5.13 
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DISCUSSION 
This study shows that A549 subpopulations T20 and T27 
differ significantly in Cd** cytotoxic response. The 
difference is not due to differing Cd^* uptake or MT 
synthesis rates in the two subpopulations. Although GSH 
plays an important protective role in the early Cd-cytotoxic 
response of both A549-T27 cells and mice (Kang and Enger, 
1988; Singhal et al., 1987), the results show that a 
difference in the basal levels of GSH cannot account for the 
great difference in Cd resistance between T20 and T27. 
That the more Cd** resistant T27 cells accumulate more 
Cd** than T20 cells (under relevant experimental conditions) 
suggests that T27 cells have a greater ability to handle 
intracellular Cd** than T20 cells do. The results also 
suggest that Cd** uptake and accumulation do not necessarily 
correlate with Cd resistance. This accords with the 
observation of Fischer (1985). 
According to Glennas and Rugstad (1984), cadmium exists 
in at least two pools within the cells. One is relatively 
loosely bound, i.e., non-MT-bound Cd**, and the other is 
tightly bound, i.e., MT-bound Cd**. The amount of 
non-MT-bound Cd** seems to determine Cd** cytotoxicity. 
Because Cd** induced MT accumulation rates are comparable, 
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there should be similar amounts of CdMT in T20 and T27 
cells. A critical difference in non-MT Cd^^ ligands between 
Cd** resistant and Cd** sensitive subpopulations is thus 
suggested as one possible explanation for the difference.in 
Cd-resistance of the two subpopulations. Among the 
non-MT-bound Cd, another kind of complex with tightly bound 
Cd may exist (Hart and Keating, 1980; Griffith et al., 
1981), whose Cd**-binding ligand is present to a greater 
relative extent in the Cd** resistant subpopulation 
(Griffith et al., 1981). This possibility will be tested in 
109 ++ future studies on Cd -binding ligands in T20 and T27. 
The difference in GSH kinetics in the two 
subpopulations, either Cd**-treated or non-Cd** treated, 
suggests a difference in their GSH metabolism. This 
difference could be in the activities of GSH metabolic 
enzymes. Meredith and Williams (1986) have shown that 
normal rat liver ARL-16C^ cells and their transformed 
derivative ARL-IET^ have very different levels of 
/^glutamyl transpeptidase, with ARL-16Tg having a high level 
of, and ARL-15C^ having no detectable activity for this 
enzyme. The intracellular orientation of this enzyme 
ensures that it catalyzes intracellular GSH recycling and 
thereby reutilization of cysteine from GSH catabolism. 
Although GSH pools are of comparable size in the two cells, 
depletion and repletion of cysteine in them is very 
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different In response to perturbations in metabolic pathways 
Involving cysteine and GSH. Another enzyme which may be 
Involved Is glutathione reductase. Tew et al. (1985) 
reported that the total cellular GSH pools are similar In 
rat cell liver WR and WS cells, but that glutathione 
reductase activity Is lower In WR than that In WS. This 
difference makes the cells respond differently to drugs. 
The present study shows that T20 and T27 cells have 
comparable basal GSH contents but their GSH levels respond 
differently to Cd** treatment. The more sensitive 
1 1  
subpopulation T20 responds to Cd with an early and 
pronounced decrease in GSH level. Whether these Cd** 
induced changes in GSH content are due to difference in the 
activities of GSH metabolic enzymes between the two 
subpopulations needs to be further investigated. Although 
the significance of GSH kinetic changes in Cd** cytotoxic 
response is uncertain, the fact that the early decrease in 
GSH level only happens in the Cd**-sensitive subpopulation 
is suggestive of an Involvement of differential GSH 
metabolism in differential Cd** cytotoxic response. 
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SUMMARY DISCUSSION 
Depletion of cellular 6SH in A549-T27 cells via the 
differential mechanisms involved in the actions of BSO and 
DEM sensitizes the cells to Cd** (Section 1). Although it 
is necessary to consider the side effects of the drug 
treatments which would augment the sensitization process, 
that GSH is importantly involved in cadmium cytotoxic 
response is clearly shown in this study. Most likely, as 
shown in the study of Section 2, GSH is involved in 
establishing a threshold for Cd** cytotoxic responses, and 
in the early cadmium cytoprotective response. 
Results obtained from the study of GSH content as a 
function of cell growth stage (Section 3) validated the 
conclusion from Section 1 that GSH plays an important role 
in cadmium cytoprotection. Moreover, this study showed that 
cellular GSH content in the A549-T27 cells changes as a 
function of cell growth stages. These changes provide an 
advantageous experimental tool for studies not only on 
cadmium toxicity but also on other toxicants of biological 
significance. That is, they can be used to define the 
relative extent to which cell growth stage and cellular GSH 
content are important in determining variations in cellular 
toxic responses. The naturally occurring changes in GSH 
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content as a function of cell growth also provide a means to 
study the role of 6SH content in cytotoxic response without 
the side effects and/or the interactions of drugs caused by 
using GSH modulating drugs. 
To define the mechanism(s) by which GSH plays its role 
in protection against Cd** cytotoxic effects, several basic 
cellular protective mechanisms must be first considered. 
First, Cd** (and other toxicants) uptake and intracellular 
accumulation are important determinants in its (and their) 
overall cytotoxicity. Cells, especially tumor cells, have 
developed mechanisms to change their membrane transport or 
intracellular accumulation processes to modulate a 
toxicant's action. Relatively high cadmium sensitivity in 
the AlOlD human melanoma cell line and variation in response 
among its subpopulations are due to enhanced and 
differential cadmium uptake, respectively (Enger et al., 
1986). An important phenomenon often expressed in tumor 
cells is multidrug resistance (mdr). Studies on drug 
transport and its relation to mdr have shown that reduced 
drug uptake is involved in most cases of mdr in vitro and in 
vivo (Sirotnak et al., 1986; Teeter et al., 1986; 
Willingham et al., 1986; Riorden and Long, 1985). Recent 
studies revealed that increased efflux is another important 
determinant in mdr (Chen et al., 1986; Fojo et al., 1987; 
Shen et al., 1986). Second, compensatory mechanisms 
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function in cellular protection. This type of mechanism is 
related to the resistance due to an increase in the amount 
of the targets for the toxicants, which are often the 
products (enzymes) of genes amplified in the course of 
cellular stimulation by drugs (Dolnick et al., 1979; 
Kaufman and Schimke, 1981; Haber and Schimke, 1981; Heintz 
and Hamlin, 1982). Third, in addition to compensatory 
responses that provide cytoprotection by overproduction or 
alteration of cytotoxic target enzymes or molecules, cells 
can be protected by mechanisms involving non-target ligands. 
Metallothionein is such a cadmium binding non-target ligand. 
Studies both in vivo and in vitro have shown that 
metallothionein(s) play a key role in conferring protection 
against cadmium (Webb, 1979; Webb, 1986; Enger et al., 1986; 
Hildebrand et al., 1982). Cadmium accumulates in vivo as a 
cadmium-MT complex which is non-toxic within the cell. 
Further, in vivo protection against toxic doses of cadmium 
was found to be enhanced by prior exposure to lower doses of 
cadmium (Hildebrand et al., 1979; Enger et al., 1981, 1984, 
1986). Finally, metabolic detoxification is Importantly 
Involved in the cellular protection process. This mechanism 
is related to the reactions of both phase I and phase II 
biotransformations. 
In terms of the mechanism by which GSH plays a role in 
cadmium cytoprotection, two possibilities should be 
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considered. First, GSH may be directly involved in cadmium 
metabolism in the cells. Most likely, GSH forms a complex 
with cadmium to reduce its toxicity. Several studies have 
suggested the existence of this mechanism (Perrin and Watt, 
1971; Vallee and Ulmer, 1972; Jacobson and Turner, 1980; 
Christie and Costa, 1984). Another possibility is that GSH 
is indirectly involved in the cadmium cytoprotection through 
its interaction with the mechanisms discussed above. 
Since an appropriate cellular GSH status affects the 
structural and biochemical integrity of the cell membrane, 
and subsequently influences the membrane transport process 
(Kosower and Kosower, 1978), it is necessary to consider 
whether or not the changes in cellular GSH levels affect 
cellular cadmium uptake and accumulation. As shown in the 
studies of Section 4, depletion of cellular GSH by DEM or 
BSO does not significantly affect cellular cadmium 
accumulation. The possible explanation is as discussed in 
Section 4; that is, the level of GSH remaining is still high 
enough to maintain membrane integrity and cadmium transport 
thus is not affected. However, if the cellular GSH/GSSG 
ratio is experimentally changed by treating the cells with 
diamide, cellular cadmium accumulation is affected 
(unpublished data). This result suggests that membrane 
transport of cadmium is indeed related to GSH status, but 
not simply related to cellular GSH level. 
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Cellular GSH status can also affect the synthesis of 
macromolecules (Kosower and Kosower, 1978; Kosower et al., 
1972; Zehavi-Willner et al., 1971) which may be potentially 
involved in Cd"*"*" cytoprotection via compensatory and/or 
ligand binding mechanisms. Although it is not known yet 
what is/are the critical cellular targets for Cd"*"^ toxicity, 
it is clear cadmium has a high affinity for sulfhydral 
groups. Decreased cellular GSH may specifically affect the 
synthesis of SH containing cellular components or 
non-specifically inhibit protein synthesis (Kosower et al., 
1972). Interestingly, we found that depletion of cellular 
GSH by different mechanisms (through the actions of BSO and 
DEM) has a differential effect on MT synthesis. This 
differential response is consistent with the model presented 
in Section 4 which suggests that the intracellular cysteine 
pool limits metallothionein synthesis as well as GSH 
synthesis. Further evidence for this model was obtained 
when L-2-oxothiazolidine-4-carboxylate (OTC) was used as an 
intracellular cysteine delivery system (Anderson and 
Meister, 1987). OTC was observed to protect cells from DEM 
enhanced Cd** cytotoxicity and to overcome DEM decreased MT 
accumulation (unpublished data). 
That GSH may be involved in metabolic detoxification of 
cadmium is suggested by the differential GSH metabolic 
changes and corresponding differential Cd** cytotoxic 
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responses seen in A549-T20 and -T27 cells (Section 5). A 
possible mechanism for such (differential) Cd**-induced 
changes in GSH content is that cadmium may cause an 
oxidative stress to the cells; it is known that cadmium can 
cause lipid peroxidation (Stacey et al., 1980; Ochi et al., 
1987), and GSH plays a very important role in protection 
against oxidative stress (Imlay and Linn, 1988; Ishikawa et 
al., 1986; Sies, 1986; Reed and Fariss, 1984). 
More study is necessary to further define the 
mechanisms by which GSH plays a protective role in 
protection against cadmium. However, from the studies 
presented here a differential contribution of GSH and MT to 
cadmium cytoprotection is indicated. Two factors are known 
to be important in protection against cadmium la vivo in 
mammalian systems, glutathione and metallothionein. Both 
contain 1/3 cysteine although there is a big difference in 
their molecular weight. The significant difference between 
them is that glutathione is a pre-existing cellular 
component and a storage form of cysteine, while 
metallothionein is an inducible protein which uses cysteine 
as a precursor for its synthesis. These differences can 
cause them to contribute differentially to protection 
against cadmium: 
1. Temporally, GSH offers a first line of defense 
against cadmium (as shown in Section 2 and by the study by 
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Slnghal et al., 1987). This is due to the fact that 
induction of metallothionein biosynthesis by cadmium is 
relatively slow; for example, cadmium-induced MT synthesis 
in hepatocytes has a 6-12 hour lag and a significant 
increase in MT occurs between 12 and 24 hours following Cd***^ 
exposure (Gerson and Shaikh, 1982). Considerable toxicity 
produced by cadmium could thus occur before establishment of 
effective levels of MT. 
2. Quantitatively, as shown in the studies of Section 
4, BSO treatment enhanced cadmium induced MT synthesis and 
accumulation. However, this treatment still sensitized the 
cells to cadmium due to the depletion of cellular GSH. This 
suggests that the protective effect of GSH can not be 
substituted by free cysteine or some other SH containing 
components, nor by metallothionein. 
3. Both GSH and MT mechanisms can involve the 
formation of a complex with cadmium (Webb, 1979; Perrin and 
Watt, 1971). However, the multifunctional features of GSH 
in the cells provide more mechanisms other than complex 
formation with cadmium. The study of such could be an 
important future research direction. 
In summary, this study indicated that GSH is 
importantly involved in the cadmium cytotoxic response in 
human lung carcinoma cells. It was shown to function 
mutually with metallothionein in cellular protection against 
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cadmium. Differential contributions of 6SH and MT to 
cellular cadmium protection were also illustrated. Further 
studies are necessary to define specific cytotoxic effects 
and their modulation. 
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